10-Q

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended August 31, 2013

[   ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______to _______

Commission File Number: 333-132456

SECURITY DEVICES INTERNATIONAL, INC.
(Exact Name of Registrant as Specified in its Charter)

Delaware	71-1050654
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

1101 Pennsylvania Ave., NW, 6th Floor
Washington, DC 20004
(Address of Principal Executive Offices) (Zip Code)

Registrant's telephone number including area code: 202-538-1677

N/A
Former name, former address, and former fiscal year, if changed since last report

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X]     No [   ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes [X]     No [   ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Larger accelerated filer [   ]	Accelerated filer                   [   ]
Non-accelerated filer    [   ]	Smaller reporting company [X]

Indicate by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes [   ]     No [X]

As of October 15, 2013, the Company had 46,849,285 issued and outstanding shares of common stock

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)

INTERIM FINANCIAL STATEMENTS

AUGUST 31, 2013

(Amounts expressed in US Dollars)

(Unaudited)

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)

INTERIM FINANCIAL STATEMENTS

AUGUST 31, 2013

(Amounts expressed in US Dollars)
(Unaudited)

TABLE OF CONTENTS

	Page No
Interim Balance Sheets as at August 31, 2013 and November 30, 2012	1
Interim Statements of Operations and Comprehensive loss for the nine months and three months ended August 31, 2013 and August 31, 2012 and the period from inception (March 1, 2005) to August 31, 2013	2
Interim Statements of Cash Flows for the nine months ended August 31, 2013 and August 31, 2012 and the period from inception (March 1, 2005) to August 31, 2013	3
Interim Statements of Changes in Stockholders’ Deficit for the nine months ended August 31, 2013 and the period from inception (March 1, 2005) to November 30, 2012	4
Condensed Notes to Interim Financial Statements	5-12

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)
Interim Balance Sheets
As at August 31, 2013 and November 30, 2012
(Amounts expressed in US Dollars)

	August 31,		November 30,
	2013		2012
	(unaudited)		(audited)
	$		$
ASSETS
CURRENT
Cash	2,888,217		232,471
Deferred costs	-		32,500
Prepaid expenses and other receivables	14,029		7,200
Total Current Assets	2,902,246		272,171
Property and Equipment (Note 4)	162,612		145,048
TOTAL ASSETS	3,064,858		417,219
LIABILITIES
CURRENT LIABILITIES
Accounts payable and accrued liabilities	343,241		150,368
Loan from related party (Note 12)	94,970
Loans from non-related parties (Note 11)	522,335		-
Total Current Liabilities	960,546		150,368
Convertible Debentures (Note 10)	-		1,192,639
Total Liabilities	960,546		1,343,007
Going Concern (Note 2)
Related Party Transactions (Note 8)
Commitments (Note 9)
STOCKHOLDERS' EQUITY (DEFICIT)
Capital Stock (Note 5)
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil issued      and outstanding (2012 - nil)
Common stock, $0.001 par value, 100,000,000 shares authorized, 45,575,907      issued and outstanding (2012 -31,472,433)	45,576		31,472
Additional Paid-In Capital	22,831,887		18,338,886
Deficit Accumulated During the Development Stage	(20,773,151	)	(19,296,146	)
Total Stockholders' Equity (Deficit)	2,104,312		(925,788	)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	3,064,858		417,219

See condensed notes to the interim financial statements.

1

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)
Interim Statements of Operations and Comprehensive loss
For the Nine months and Three Months Ended August 31, 2013 and August 31, 2012 and the Period from Inception
(March 1, 2005) to August 31, 2013
(Amounts expressed in US Dollars)
(Unaudited)

			For the		For the		For the		For the
			nine months		nine months		three months		three months
	Cumulative		ended		ended		ended		ended
	Since		August 31,		August 31,		August 31,		August 31,
	inception		2013		2012		2013		2012
			$		$		$		$
OPERATING EXPENSES:
Research and product
Development cost (recovery)	7,473,781		-		(215,143	)	-		-
Amortization	88,599		27,655		11,827		10,474		7,141
General and administration	13,111,347		1,305,110		1,027,875		377,202		305,955
TOTAL OPERATING EXPENSES	20,673,727		1,332,765		824,559		387,676		313,096
LOSS FROM OPERATIONS	(20,673,727	)	(1,332,765	)	(824,559	)	(387,676	)	(313,096	)
Other expense- Interest	(372,018	)	(144,240	)	(126,711	)	(56,919	)	(37,534	)
Other Income-Interest	272,594		-		-		-		-
LOSS BEFORE INCOME TAXES	(20,773,151	)	(1,477,005	)	(951,270	)	(444,595	)	(350,630	)
Income taxes	-		-		-		-		-
NET LOSS	(20,773,151	)	(1,477,005	)	(951,270	)	(444,595	)	(350,630	)
Loss per share – basic and diluted			(0.04	)	(0.04	)	(0.01	)	(0.01	)
Weighted average common shares outstanding			33,215,599		27,031,172		33,961,413		27,433,000

See condensed notes to the interim financial statements.

2

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)
Interim Statements of Cash Flows
For the Nine Months Ended August 31, 2013 and August 31, 2012 and the Period from Inception (March 1, 2005) to
August 31, 2013
(Amounts expressed in US Dollars)
(Unaudited)

			For the		For the
			nine months		nine months
	Cumulative		ended		ended
	since inception		August 31,		August 31,
	(March 1, 2005	)	2013		2012
	$		$		$
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss for the period	(20,773,151	)	(1,477,005	)	(951,270	)
Items not requiring an outlay of cash:
Issue of shares for services	584,500		-		-
Fair value of options and warrants (included in general                                       and administration expenses)	6,585,016		99,245		288,453
Recovery of accounts payable	(215,143	)	-		(215,143	)
Loss on cancellation of common stock	34,400		-		-
Amortization of plant and equipment	88,599		27,655		11,827
Amortization of debt discount	79,300		37,361		19,256
Amortization of deferred financing cost	35,160				10,916
Changes in non-cash working capital: repaid expenses                                      and other receivables	(14,029	)	(6,829	)	98,392
Deferred costs	-		32,500		-
Accounts payable and accrued liabilities*	753,043		331,033		(144,217	)
NET CASH USED IN OPERATING ACTIVITIES	(12,842,305	)	(956,040	)	(881,786	)
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of Plant and Equipment	(251,211	)	(45,219	)	(147,219	)
NET CASH USED IN INVESTING ACTIVITIES	(251,211	)	(45,219	)	(147,219	)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from issuance of common shares	13,538,600		3,069,700		400,000
Proceeds (repayment) from convertible debentures	1,758,328		(30,000	)	910,000
Cancellation of common stock	(50,000	)	-		-
Loan from related party	94,970		94,970		-
Loan from non-related parties	522,335		522,335		-
Exercise of stock options	117,500		-		-
NET CASH PROVIDED BY FINANCING ACTIVITIES	15,981,733		3,657,005		1,310,000
NET INCREASE IN CASH FOR THE PERIOD	2,888,217		2,655,746		280,995
Cash, beginning of period	-		232,471		114,835
CASH, END OF PERIOD	2,888,217		2,888,217		395,830
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS:
INCOME TAXES PAID	-		-		-
INTEREST PAID	-		6,901		-

*Excludes the conversion of accrued interest for $138,160 into common shares during the nine month period ended August 31, 2013

See condensed notes to the interim financial statements.

3

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)
Interim Statement of Changes in Stockholders’ Deficit
For the period from inception (March 1, 2005) to August 31, 2013.
(Amounts expressed in US Dollars)
(Unaudited)

	Number of		Common		Additional		Deficit
	Common		Shares		Paid-in		Accumulated
							During
	Shares		amount		Capital		Development		Total
							Stage
			$		$		$		$
Balance as of March 1, 2005	-		-		-		-		-
Issuance of Common shares for professional services	6,525,000		6,525		58,725		-		65,250
Issuance of common shares for cash	397,880		398		99,072				99,470
Net loss for the period	-		-		-		(188,699	)	(188,699	)
Balance as of November 30, 2005	6,922,880		6,923		157,797		(188,699	)	(23,979	)
Issuance of common shares for cash	956,000		956		94,644		-		95,600
Issuance of common shares for cash	286,000		286		49,764		-		50,050
Issuance of common shares to consultant for services	50,000		50		8,700		-		8,750
Issuance of common shares for cash	2,000,000		2,000		398,000		-		400,000
Exercise of stock options	950,000		950		94,050		-		95,000
Issuance of common shares for cash (net of agent commission)	200,000		200		179,785		-		179,985
Stock subscriptions received					1,165,500		-		1,165,500
Stock based compensation	-		-		1,049,940		-		1,049,940
Net loss for the year	--		-		--		(1,660,799	)	(1,660,799	)
Balance as of November 30, 2006	11,364,880		11,365		3,198,180		(1,849,498	)	1,360,047
Issuance of common shares for stock
Subscriptions received in prior year	1,165,500		1,165		(1,165	)	-		-
Issuance of common shares for cash	1,170,670		1,171		1,169,499				1,170,670
Issuance of common shares for cash and services	50,000		50		154,950				155,000
Issuance of common shares for cash (net of expenses)	2,139,000		2,139		4,531,236				4,533,375
Cancellation of stock	(1,560,000	)	(1,560	)	(14,040	)			(15,600	)
Stock based compensation					2,446,433				2,446,433
Issue of warrants					357,094				357,094
Net loss for the year	-		-		-		(4,827,937	)	(4,827,937	)
Balance as of November 30, 2007	14,330,050		14,330		11,842,187		(6,677,435	)	5,179,082
Exercise of stock options	117,000		117		11,583				11,700
Stock based compensation	-		-		1,231,056		-		1,231,056
Net loss for the year	-		-		-		(4,401,786	)	(4,401,786	)
Balance as of November 30, 2008	14,447,050		14,447		13,084,826		(11,079,221	)	2,020,052
Issuance of common shares for cash	788,000		788		196,212				197,000
Stock based compensation	-		-		177,990		-		177,990
Compensation expense for warrants					4,223				4,223

See condensed notes to the interim financial statements.

4

Net loss for the year	-	-	-		(2,974,467	)	(2,974,467	)
Balance as of November 30, 2009	15,235,050	15,235	13,463,251		(14,053,688	)	(575,202	)
Issuance of common shares for cash	8,143,000	8,143	1,665,157				1,673,300
Issuance of common shares for services	2,500,000	2,500	428,000				430,500
Stock subscriptions received			30,000				30,000
Stock based compensation			289,670				289,670
Net loss for the year					(2,320,962	)	(2,320,962	)
Balance as of November 30, 2010	25,878,050	25,878	15,876,078		(16,374,650	)	(472,694	)
Issuance of common shares for cash	800,000	800	159,200				160,000
Common shares issued for stock subscriptions received in prior year	150,000	150	(150	)
Beneficial conversion feature on Convertible debt			29,300				29,300
Net loss for the year					(901,558	)	(901,558	)
Balance as of November 30, 2011	26,828,050	26,828	16,064,428		(17,276,208	)	(1,184,952	)
Beneficial conversion features on convertible debt			50,000				50,000
Conversion of convertible debt to common shares	2,478,549	2,479	647,508				649,987
Issuance of common shares for cash	2,165,834	2,165	647,585				649,750
Stock based compensation			929,365				929,365
Net loss for the year					(2,019,938	)	(2,019,938	)
Balance as of November 30, 2012	31,472,433	31,472	18,338,886		(19,296,146	)	(925,788	)
Conversion of convertible debt to common shares	1,801,480	1,802	538,642				540,444
Conversion of convertible debt to common shares	2,297,044	2,297	795,419				797,716
Issuance of common shares for cash	9,984,950	9,985	3,059,715				3,069,700
Common share reconciliation difference with transfer agent	20,000	20	(20	)
Stock based compensation			99,245				99,245
Net loss for the period					(1,477,005	)	(1,477,005	)
Balance as of August 31, 2013	45,575,907	45,576	22,831,887		(20,773,151	)	2,104,312

See condensed notes to the interim financial statements.

5

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)
Notes to Financial Statements
August 31, 2013
(Amounts expressed in US Dollars)
(Unaudited)

1.	BASIS OF PRESENTATION
	The unaudited interim financial statements include the accounts of Security Devices International Inc. (the “Company” or “SDI”). The Company was incorporated under the laws of the state of Delaware on March 1, 2005.
	The accompanying unaudited interim financial statements have been prepared in accordance with the instructions to Form 10-Q and therefore do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with U.S. generally accepted accounting principles (GAAP); however, such information reflects all adjustments (consisting solely of normal recurring adjustments), which are, in the opinion of management, necessary for a fair statement of the results for the interim periods.
	The interim unaudited financial statements should be read in conjunction with the financial statements and Notes thereto together with management’s discussion and analysis of financial condition and results of operations contained in the Company’s annual report on Form 10-K for the year ended November 30, 2012. In the opinion of management, the accompanying unaudited financial statements reflect all adjustments of a normal recurring nature considered necessary to fairly state the financial position of the Company at August 31, 2013, the results of its operations for the nine -and three-month periods ended August 31, 2013 and August 31, 2012, and its cash flows for the nine -month periods ended August 31, 2013 and August 31, 2012. In addition, some of the Company’s statements in this quarterly report on Form 10-Q may be considered forward-looking and involve risks and uncertainties that could significantly impact expected results. The results of operations for the nine -month period ended August 31, 2013 are not necessarily indicative of results to be expected for the full year.
	The Company was incorporated under the laws of the state of Delaware on March 1, 2005.
2.	NATURE OF OPERATIONS
	The Company is a non-lethal defense technology company, specializing in the development of innovative next generation solutions for security situations that do not require the use of lethal force. SDI has implemented manufacturing partnerships to assist in the deployment of their patented and patent pending family of products. These products consist of: the Blunt Impact Projectile 40mm (BIP) line of products and the Wireless Electric Projectile 40mm (WEP).
	These unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year.
	The Company is in the development stage and has not yet realized revenues from its planned operations. The Company has incurred a cumulative loss of $20,773,151 from inception to August 31, 2013 which includes a non-cash stock based compensation expense of $6,585,016 for issue of options and warrants. The Company has funded operations through the issuance of capital stock and convertible debentures.

6

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)
Notes to Financial Statements
August 31, 2013
(Amounts expressed in US Dollars)
(Unaudited)

2.	NATURE OF OPERATIONS AND GOING CONCERN-Cont’d
	In addition to raising funds in the prior years, the Company raised $160,000 through the issuance of 800,000 common shares during the year ended November 30, 2011. The Company further raised an additional $878,328 by issue of Convertible Debentures during the year ended November 30, 2011 and $910,000 during the year ended November 30, 2012. In addition, the Company raised $649,750 by issuance of 2,165,834 common shares during the year ended November 30, 2012. On August 15, 2013, the Company filed an amended and restated final prospectus (the “Prospectus”) in Canada, in the provinces of Alberta, British Columbia and Ontario for listing its shares in these provinces in Canada. On August 27, 2013 the Company completed an initial public offering to raise gross proceeds of CDN $3,993,980 (US $3,794,280) through the issuance of 9,984,950 Common Shares at a price of CDN$0.40 (US $0.38) per Common Share (the “Issue Price”). The Company’s common shares commenced trading on the TSX Venture Exchange (“TSX”) under the symbol “SDZ”.
	While the Company has been successful in securing financings in the past, there is no assurance that it will be able to do so in the future. Accordingly, these financial statements do not give effect to adjustments, if any, that would be necessary should the Company be unable to continue as a going concern.
3.	RESEARCH AND PRODUCT DEVELOPMENT
	Research and Product Development costs, including acquired research and product development costs, are charged against income in the period incurred.

7

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)
Notes to Financial Statements
August 31, 2013
(Amounts expressed in US Dollars)
(Unaudited)

4.	PROPERTY AND EQUIPMENT
	Property and equipment are recorded at cost less accumulated depreciation. Depreciation is provided commencing in the month following acquisition using the following annual rate and method:

Computer equipment	30%	declining balance method
Furniture and Fixtures	30%	declining balance method
Leasehold Improvements		straight line over period of lease
Moulds	20%	Straight line over 5 years

	August 31, 2013				November 30, 2012
			Accumulated				Accumulated
	Cost		Amortization		Cost		Amortization
	$		$		$		$
Computer equipment	37,573		30,592		37,573		28,565
Furniture and fixtures	18,027		13,575		18,027		12,282
Leasehold Improvements	23,721		9,283		8,252		8,252
Moulds	171,890		35,149		142,140		11,845
	251,211		88,599		205,992		60,944
Net carrying amount		$	162,612			$	145,048
Amortization expense		$	27,655			$	20,585
			(9 months	)			(12 months	)

5. CAPITAL STOCK

a)	Authorized
	100,000,000* Common shares, $0.001 par value And        5,000,000 Preferred shares, $0.001 par value

*On March 20, 2013 the Company filed with the Secretary of the State of Delaware a certificate of amendment (the “Amendment”) to the Company’s certificate of incorporation. The Amendment increased the number of authorized shares of the Company’s common stock, par value $0.001, from 50,000,000 to 100,000,000 common shares.

The Company’s Articles of Incorporation authorize its Board of Directors to issue up to 5,000,000 shares of preferred stock. The provisions in the Articles of Incorporation relating to the preferred stock allow the directors to issue preferred stock with multiple votes per share and dividend rights, which would have priority over any dividends paid with respect to the holders of SDI’s common stock.

b)	Issued
	45,575,907 Common shares

8

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)
Notes to Financial Statements
August 31, 2013
(Amounts expressed in US Dollars)
(Unaudited)

5. CAPITAL STOCK-Cont’d

c)	Changes to Issued Share Capital
	Nine- months ended August 31, 2013
	During the six month period ended May 31, 2013 the Company issued 1,801,480 common shares for conversion of convertible debentures having face value of $500,000 and accrued interest of $40,444. The total debt for $540,444 was converted into 1,801,480 common shares at $0.30 per share.
	On August 15, 2013, the Company filed an amended and restated final prospectus (the “Prospectus”) in Canada, in the provinces of Alberta, British Columbia and Ontario to list its common shares (“Common Shares”) on the TSXV.
	On August 27, 2013, the Company completed an initial public offering to raise gross proceeds of $3,794,280 (CAD $3,993,980) through the issuance of 9,984,950 Common Shares at a price of $0.38 (CAD$0.40) per Common Share (the “Issue Price”). The company incurred expenses of $734,565 to raise the capital which included a fee of CAD $80,000 paid to a former director and CEO in accordance with the terms of an agreement regarding escrow of shares and a cash commission of CAD$359,458 paid to the Agent. In addition the Company granted an option (the “Agent’s Option”) to purchase up to 898,645 Common Shares to the Agent and members of its selling group. The Agent’s Option entitles the Agent and members of its selling group to purchase Common Shares at a price of CAD$0.40 (US $0.38) per Common Share until August 27, 2015.
	Upon completion of the Offering, $700,000 face value of convertible debentures along with $97,716 of interest was converted to 2,297,044 Common Shares, resulting in the discharge of those debentures.
	Year ended November 30, 2012
	During the three month period ended August 31, 2012, the Company issued 1,484,169 common shares for conversion of convertible debentures having face value of $411,828 (Convertible debenture 2) and accrued interest of $33,423. The total debt for $445,251 was converted into 1,484,169 common shares at $0.30 per share.
	During the three month period ended August 31, 2012, the Company issued 1,333,333 shares of common stock to private investors at a price of $0.30 per share for a total consideration of $400,000. The shares of common stock are restricted securities, as that term is defined in Rule 144 of the Securities and Exchange Commission. The Company relied upon the exemption provided by Section 4(2) of the Securities Act of 1933 in connection with the sale of these securities.
	During the three month period ended November 30, 2012, the Company issued 994,380 common shares for conversion of convertible debentures having a face value of $146,500 (Convertible debenture 1) and accrued interest of $23,076. The total debt for $169,576 was converted into 994,380 common shares.
	During the three month period ended November 30, 2012, the Company issued 832,501 shares of common stock to private investors at a price of $0.30 per share for a total consideration of $249,750. The shares of common stock are restricted securities, as that term is defined in Rule 144 of the Securities and Exchange Commission. The Company relied upon the exemption provided by Section 4(2) of the Securities Act of 1933 in connection with the sale of these securities.

6.	STOCK BASED COMPENSATION
	Effective October 30, 2006 the Company adopted the following stock option and stock bonus plans which were replaced by the incentive stock option plan (the “2013 Plan”)
	Incentive Stock Option Plan. The Company’s Incentive Stock Option Plan authorizes the issuance of shares of its Common Stock to persons that exercise options granted pursuant to the Plan. Only employees may be granted options pursuant to the Incentive Stock Option Plan. The option exercise price is determined by its directors but cannot be less than the market price of its common stock on the date the option is granted. The Company has reserved 1,000,000 common shares under this plan. No options have been issued under this plan as at August 31, 2013.
	Non-Qualified Stock Option Plan. SDI’s Non-Qualified Stock Option Plan authorizes the issuance of shares of its Common Stock to persons that exercise options granted pursuant to the Plans. SDI’s employees, directors, officers, consultants and advisors are eligible to be granted options pursuant to the Plans, provided however that bona fide services must be rendered by such consultants or advisors and such services must not be in connection with the offer or sale of securities in a capital-raising transaction. By a resolution of the Board of Directors, the Company amended this plan to increase the number of common shares available under this plan from 2,250,000 to 4,500,000 effective October 10, 2007. The Company further amended its Non-Qualified Stock Option Plan to increase the number of Common Shares available under this plan to 5,000,000 and filed an S-8 registration statement on April 10, 2008.

9

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)
Notes to Financial Statements
August 31, 2013
(Amounts expressed in US Dollars)
(Unaudited)

6.	STOCK BASED COMPENSATION-Cont’d
	Stock Bonus Plan. SDI’s Stock Bonus Plan allows for the issuance of shares of common stock to its employees, directors, officers, consultants and advisors. However bona fide services must be rendered by the consultants or advisors and such services must not be in connection with the offer or sale of securities in a capital-raising transaction. The Company has reserved 150,000 common shares under this plan. No options have been issued under this plan as at August 31, 2013.
	Effective May 31, 2013, the Company adopted an incentive stock option plan (the “2013 Plan”), which replaces the stock option and stock bonus plans that were in place prior to adoption of the 2013 Plan. All outstanding options to purchase Common Shares granted by the Company under the prior plans are now governed by the 2013 Plan and the prior plans (an Incentive Stock Option Plan, a Non-Qualified Stock Option Plan, and a Stock Bonus Plan) have been terminated.
	The 2013 Plan authorizes the issuance that number of Common Shares as is equal to 20% of the issued and outstanding Common Shares. As a condition precedent to the TSXV issuing its final acceptance of listing of the Common Shares on the TSXV, all of the warrants previously issued by the Corporation in satisfaction of remuneration for services (in aggregate, warrants entitling the purchase of 4,319,000 Common Shares that were outstanding as of the date of filing of the amended and restated prospectus on August 15, 2013) are considered for purposes of the 2013 Plan reserve to be incentive stock options and included under the 2013 Plan reserve.
	The Board of Directors administers the 2013 Plan. The Corporation’s employees, directors, officers, consultants and advisors are eligible to be granted options pursuant to 2013 Plan and in accordance with the policies of the TSXV, provided however that bona fide services must be rendered by such consultants or advisors and such services must not be in connection with the offer or sale of securities in a capital-raising transaction. In no instance shall an option be less than the market price of the Common Shares; the period during which options may be exercised cannot exceed ten years from the date of grant. No option shall be transferable or assignable. If there is any reclassification, consolidation or merger, the number of Common Shares subject to option and the option price per Common Share shall be proportionately adjusted in accordance with the terms of the 2013 Plan. The Board may attach other terms to the options at the time of grant. The Plan shall be governed by the laws of the Province of Ontario.
	Year ended November 30, 2012
	On January 4, 2012, the board of directors granted options to three directors to acquire a total of 775,000 common shares, one officer to acquire 20,000 common shares and two consultants to acquire a total of 110,000 common shares. The 905,000 options were issued at an exercise price of $0.13 per share and vest immediately with an expiry term of four years. The fair value of each option used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		2.00%
Expected dividends		0%
Forfeiture rate		0%
Volatility		206.87%
Market price of Company’s common stock on date of grant of options	$	0.13
Stock-based compensation cost	$	113,292

On September 19, 2012 the board of directors approved the cancellation of all the 905,000 options issued on January 4, 2012, as detailed above and to be exchanged into 905,000 warrants on terms identical to the terms of the existing stock options in the Company. The cancellation of 905,000 options and issuance of 905,000 warrants in lieu thereof was effective October 8, 2012.

On March 9, 2012, all of the issued and outstanding stock options for common shares in the Company’s capital stock previously issued to Elad, Ilan Shalev and Haim Danon (being principals of Elad) were exchanged into warrants on terms identical to the terms of the existing stock options in the Company. The Company thus cancelled 850,000 options having an exercise price of $0.25 per common share and expiring on June 30, 2014 and issued 850,000 warrants at exercise price of $0.25 per common share and expiring June 30, 2014.

On October 3, 2012, the board of directors granted options to two consultants to acquire 100,000 common shares each for a total of 200,000 common shares. The 200,000 options were issued at an exercise price of $0.42 per share and vest immediately with an expiry term of three years. The fair value of each option used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

10

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)
Notes to Financial Statements
August 31, 2013
(Amounts expressed in US Dollars)
(Unaudited)

Risk free rate		1.50%
Expected dividends		0%
Forfeiture rate		0%
Volatility		199.60%
Market price of Company’s common stock on date of grant of options	$	0.42
Stock-based compensation cost	$	77,096

On October 26, 2012, the board of directors granted options to one director to acquire a total of 1,000,000 common shares and to another director to acquire 100,000 common shares for a total of 1,100,000 options. These 1,100,000 options were issued at an exercise price of $0.45 per share and vest immediately with an expiry term of four years. The fair value of each option used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		1.65%
Expected dividends		0%
Forfeiture rate		0%
Volatility		217.15%
Market price of Company’s common stock on date of grant of options	$	0.50
Stock-based compensation cost	$	534,905

As of November 30, 2012 there was $Nil of unrecognized expense related to non-vested stock-based compensation arrangements granted.

Nine months ended August 31, 2013

The Company did not issue any options during the nine month period ended August 31, 2013

As of August 31, 2013 there was $Nil of unrecognized expense related to non-vested stock-based compensation arrangements granted.

11

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)
Notes to Financial Statements
August 31, 2013
(Amounts expressed in US Dollars)
(Unaudited)

7.	STOCK PURCHASE WARRANTS
	Year ended November 30, 2012
	On January 4, 2012, the board of directors issued warrants to a Company in which the Chief Operating officer has an interest in, to acquire a total of 800,000 common shares. These warrants were issued at an exercise price of $0.13 per share with an expiry term of four years. The Company expensed stock based compensation cost of $100,148. The fair value of each warrant used for the purpose of estimating the compensation expense is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		2.00%
Expected dividends		0%
Forfeiture rate		0%
Volatility		206.87%
Market price of Company’s common stock on date of grant of options	$	0.13
Compensation expense	$	100,148

On March 9, 2012, all of the issued and outstanding stock options for common shares in the Company’s capital stock previously issued to Elad, Ilan Shalev and Haim Danon (being principals of Elad) were exchanged into warrants on terms identical to the terms of the existing stock options in the Company. The Company thus cancelled 850,000 options having an exercise price of $0.25 per common share and expiring on June 30, 2014 and issued 850,000 warrants at exercise price of $0.25 per common share and expiring June 30, 2014 (see note 6)

On August 9, 2012, the board of directors issued warrants to a Company owned and controlled by a director, to acquire a total of 400,000 common shares. These warrants were issued at an exercise price of $0.20 per share with an expiry term of four years. The Company expensed stock based compensation cost of $75,013. The fair value of each warrant used for the purpose of estimating the compensation expense is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		3.63%
Expected dividends		0%
Forfeiture rate		0%
Volatility		183.31%
Market price of Company’s common stock on date of grant of options	$	0.20
Compensation expense	$	75,013

On October 3, 2012, the board of directors issued warrants to a consultant, to acquire a total of 75,000 common shares. These warrants were issued at an exercise price of $0.42 per share with an expiry term of three years. The Company expensed stock based compensation cost of $28,911. The fair value of each warrant used for the purpose of estimating the compensation expense is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		1.5%
Expected dividends		0%
Forfeiture rate		0%
Volatility		199.60%
Market price of Company’s common stock on date of grant of options	$	0.42
Compensation expense	$	28,911

On September 19, 2012 the board of directors approved the cancellation of 905,000 options issued on January 4, 2012, to be exchanged into 905,000 warrants on terms identical to the terms of the existing stock options in the Company. The cancellation of 905,000 options and issuance of 905,000 warrants in lieu thereof was effective October 8, 2012 (see note 6).

Nine months ended August 31, 2013

On January 30, 2013, the board of directors granted 100,000 warrants as an incentive to a lender who provided a working capital loan of $193,400 (CAD $200,000). These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. The fair value of incentive warrants used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		1.35%
Expected dividends		0%
Forfeiture rate		0%
Volatility		187.87%
Market price of Company’s common stock on date
of grant of options	$	0.47
Compensation expense	$	38,183

12

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)
Notes to Financial Statements
August 31, 2013
(Amounts expressed in US Dollars)
(Unaudited)

On March 14, the board of directors granted 50,000 warrants as an incentive to a director who provided a working capital loan of $96,700 (CAD $100,000). These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. The fair value of incentive warrants used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		1.35%
Expected dividends		0%
Forfeiture rate		0%
Volatility		182.13%
Market price of Company’s common stock on date of grant of options	$	0.40
Compensation expense	$	15,637

On April 12, 2013, the board of directors granted 100,000 warrants as an incentive to a lender who provided a working capital loan of $193,400 (CAD $200,000).. These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. The fair value of incentive warrants used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		1.35%
Expected dividends		0%
Forfeiture rate		0%
Volatility		168.05%
Market price of Company’s common stock on date of grant of options	$	0.35
Compensation expense	$	25,351

On May 14, 2013, the board of directors granted 75,000 warrants as an incentive to a lender who provided a working capital loan of $145,050 (CAD$150,000). These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. The fair value of incentive warrants used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		1.35%
Expected dividends		0%
Forfeiture rate		0%
Volatility		181.17%
Market price of Company’s common stock on date of grant of options	$	0.35
Compensation expense	$	20,074

On August 27, 2013, the Company completed an initial public offering to raise gross proceeds of CDN $3,794,280 (CAD $3,993,980) through the issuance of 9,984,950 Common Shares at a price of $0.38 (CDN$0.40) per Common Share (the “Issue Price”). The Company granted an option (the “Agent’s Option”) to purchase up to 898,645 Common Shares to the Agent and members of its selling group. The Agent’s Option entitles the Agent and members of its selling group to purchase Common Shares at a price of CDN$0.40 (US $0.38) per Common Share until August 27, 2015.

13

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)
Notes to Financial Statements
August 31, 2013
(Amounts expressed in US Dollars)
(Unaudited)

8.	RELATED PARTY TRANSACTIONS
	The following transactions are in the normal course of operations and are measured at the exchange amount, which is the amount of consideration established and agreed to by the related parties.
	Nine months ended August 31, 2013
	The directors were compensated as per their consulting agreements with the Company. The Company expensed a total of $233,400 as management fees to its three directors and expensed a total of $5,400 as automobile allowance.
	The Company expensed $34,730 for services provided by the CFO of the Company and $180,000 for services provided by a corporation in which the Chief Operating Officer has an interest.
	The Company reimbursed $92,735 to directors and officers for travel and entertainment expenses incurred for the Company.
	On March 4, the board of directors granted 100,000 warrants as an incentive to a director who provided a working capital loan of $94,970 (CAD $100,000). These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. The Company expensed $15,637 as compensation expense. In addition the Company has accrued interest of $8,811 till August 31, 2013.
	Nine months ended August 31, 2012
	The directors were compensated as per their consulting agreements with the Company. The Company expensed a total of $198,000 as Management fees for payment to its three directors and expensed a total of $4,800 as automobile allowance.

On January 4, 2012, the board of directors granted options to three directors to acquire a total of 775,000 common shares and one officer to acquire 20,000 common shares. All these 795,000 options were issued at an exercise price of $0.13 per share and vest immediately with an expiry term of four years. The Company expensed stock based compensation cost of $99,522 for these options.

On January 4, 2012, the board of directors issued warrants to a Company in which the Chief Operating officer has an interest in, to acquire a total of 800,000 common shares. These warrants were issued at an exercise price of $0.13 per share with an expiry term of four years. The Company expensed stock based compensation cost of $100,148.

On August 9, 2012, the board of directors issued warrants to a Company owned and controlled by a director, to acquire a total of 400,000 common shares. These warrants were issued at an exercise price of $0.20 per share with an expiry term of four years. The Company expensed stock based compensation cost of $75,013.

The Company expensed $18,050 for services provided by the CFO of the Company and $151,600 for services provided by a Company in which the Chief Operating Officer has an interest.

9.	COMMITMENTS a) Consulting agreements:
	The directors of the Company executed consulting agreements with the Company on the following terms:
	Effective January 1, 2013, SDI executed an agreement with a Company in which a director Allan Ezer has an interest in, for a period of two years to pay compensation of $8,500 per month with a 5% increase on the first anniversary date for services rendered. Either party may terminate the consulting agreement by giving 30 days written notice.
	Agreement with the Chief Executive Officer Greg Sullivan to pay compensation of $12,000 per month, with an annual 5% increase and a car allowance of $600 per month. The agreement expires December 31, 2016. The monthly remuneration will increase with accomplishment of milestones. The agreement may be terminated with mutual consent or by the Chief Executive Officer giving three weeks notice.
	Effective October 4, 2012, SDI executed an agreement with a Company in which the Chief Operating Officer Dean Thrasher has an interest in, for a period of two years which expires September 30, 2014 for services rendered. The total consulting fees are estimated at $480,000 for the two year period. The Company expensed $180,000 during the nine month period ended August 31, 2013. The Company may also accept common shares at $0.45 per common share in lieu of cash. As of August 31, 2013, the Company has not exercised its right to accept this compensation in shares.

14

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)
Notes to Financial Statements
August 31, 2013
(Amounts expressed in US Dollars)
(Unaudited)

SDI entered into an agreement (the “Teaming Agreement”) dated November 30, 2011 with Chemring Ordnance, Inc. (“Chemring”) pursuant to which both agreed to establish a co-operative and supportive team to develop the best marketing, management and technical approach for the worldwide manufacture and sale of 40mm less that blunt trauma ammunition. The Teaming Agreement provides for SDI and Chemring to create a team for the purpose of preparing competitive, cost effective proposals in response to requests for proposals and obtaining and performing any contracts that result therefrom.

Pursuant to the Teaming Agreement, if a contract is awarded, each of SDI and Chemring will perform the work to be done by it as specified in the Teaming Agreement and will share the revenue as set out in the Teaming Agreement. Either party who initiated the proposal that led to the contract will be the prime contact for that customer. Upon a contract being awarded to either SDI or Chemring, it will subcontract with the other for the other’s share of the work. In accordance with the Teaming Agreement, the BIP ammunition sold will have Chemring’s branding unless otherwise agreed by the parties.

The Teaming Agreement will terminate on December 20, 2016. The Teaming Agreement may also expire if a time period of two years from the effective date of the agreement passes without a bona fide arms length contract being executed and delivered with respect to BIP ammunition. It will also terminate if either party is in material breach of the Agreement or a subcontract that hasn’t been resolved, if any required governmental licenses or approvals or permits are revoked, in the event of a debarment or suspension of a party at the option of the other party, and by the mutual written agreement of the parties.

The Company entered into a Development, Supply and Manufacturing Agreement with the BIP Manufacturer on July 25, 2012. This Agreement provides the Company to order and purchase only from the BIP Manufacturer certain 40MM assemblies and components for use by the Company to produce less-lethal and training projectiles as described in the Agreement. The Agreement is for a term of five years with an automatic extension for an additional year if neither party has given written notice of termination prior to the end of the five year period.

Effective January 1, 2013, SDI executed an agreement with a non-related consultant to pay compensation of $7,000 per month. The consultant is to assist with sales initiatives, demos and participate in trade shows. The agreement is for a period of one year. Either party may terminate the consulting agreement by giving 30 days written notice.

Effective January 1, 2013, SDI executed an agreement with another non-related consultant to pay compensation of $7,000 per month. The consultant is to assist with sales initiatives, demos and participate in trade shows. The agreement is for a period of one year. Either party may terminate the consulting agreement by giving 30 days written notice.

b) The Company has commitments for leasing office premises in Oakville, Ontario, Canada to April 30, 2018 at a rent of Canadian $6,399 per month.

c) The Company has commitments for leasing office premises in Tampa, Florida, USA to June 30, 2014 at a rent of $1,418 per month.

15

SECURITY DEVICES INTERNATIONAL, INC.
(A Development Stage Enterprise)
Notes to Financial Statements
August 31, 2013
(Amounts expressed in US Dollars)
(Unaudited)

10.	CONVERTIBLE DEBENTURES
	During the six month period ended May 31, 2013 the Company issued 1,801,480 common shares for conversion of convertible debentures having face value of $500,000 and accrued interest of $40,444. The total debt for $540,444 was converted into 1,801,480 common shares at $0.30 per share.
	On August 27, 2013, upon completion of the Offering, $700,000 face value of convertible debentures along with $97,716 of interest was converted to 2,297,044 Common Shares, resulting in the discharge of those debentures. In addition, the Company repaid the balance of $30,000 face value of convertible debenture not converted along with accrued interest of $3,877 and also repaid interest of $3,024 not converted to common shares.
11.	LOANS FROM NON- RELATED PARTIES

On January 30, 2013, the Company obtained an unsecured loan of $189,940 (CAD $200,000) for general working capital purposes (“Working Capital Loan”). The Working Capital Loan, together with interest at 6% per annum, accrued and calculated daily, plus $12,000 will be repaid on the earlier of July 30, 2013 and demand. The Company has accrued interest of $18,805 for the nine month period ended August 31, 2013. The Company also granted 100,000 warrants to the lender as bonus consideration for the loan. These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. This loan along with interest was converted to common shares (see subsequent event note 13 (a))

On April 12, 2013, the Company obtained an unsecured loan of $189,940 (CAD $200,000) for general working capital purposes (“Working Capital Loan”). The Working Capital Loan, together with interest at 6% per annum, accrued and calculated daily, plus $12,000 will be repaid on the earlier of July 30, 2013 and demand. The Company has accrued interest of $16,669 for the nine month period ended August 31, 2013. The Company also granted 100,000 warrants to the lender as bonus consideration for the loan. These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. This loan along with interest was repaid subsequent to the quarter (see subsequent event note 13 (b))

On May 14, 2013, the Company obtained an unsecured loan of $142,455 (CAD $150,000) for general working capital purposes (“Working Capital Loan”). The Working Capital Loan, together with interest at 6% per annum, accrued and calculated daily, plus $9,000 will be repaid on the earlier of July 30, 2013 and demand. The Company has accrued interest of $11,712 for the nine month period ended August 31, 2013. The Company also granted 75,000 warrants to the lender as bonus consideration for the loan. These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. This loan along with interest was converted to common shares (see subsequent event note 13 (a))

12.	LOAN FROM RELATED PARTY
	On March 14, 2013, the Company obtained an unsecured loan of $94,970 (CAD$100,000) for general working capital purposes (“Working Capital Loan”) from a director. The Working Capital Loan , together with interest at 6% per annum, accrued and calculated daily, plus $6,000 will be repaid on the earlier of July 30, 2013 and demand. The Company has accrued interest of $8,811 for the nine month period ended August 31, 2013. The Company also granted 50,000 warrants to the lender as bonus consideration for the loan. These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. This loan along with interest was repaid subsequent to the quarter (see subsequent event note 13 (b))
13.	SUBSEQUENT EVENTS
	a)	Subsequent to the quarter, the holder of a bridge loan exercised the holder’s right to convert the principal and interest (totaling CAD$382,014) into common shares at CAD$0.30 per share, resulting in the issuance of 1,273,378 common shares.
	b)	Subsequent to the quarter, the loan from related party for $94,970 (CAD$100,000) and loan from unrelated party for $189,940 (CAD $200,000) was repaid along with interest.

16

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF OPERATION

FOR THE NINE-MONTH AND THREE-MONTH PERIODS ENDED AUGUST 31, 2013

The following discussion and analysis of the financial condition and results of Security Devices International, Inc. (also referred to as "we", "us", "our", "SDI", or the "Company"), should be read in conjunction with the Company's financial statements (and related notes) as at November 30, 2012

The following discussion contains forward-looking statements, which are subject to risks and uncertainties and other factors that may cause SDI’s results to differ materially from expectations. When reviewing the Company's forward-looking statements, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. These include risk relating to market fluctuations, performance, , strength of the North American and other world economies and foreign exchange fluctuations. These forward-looking statements speak only as of the date hereof. Unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update these forward-looking statements. The Company does have an ongoing obligation to disclose material information as it becomes available. The discussion also includes cautionary statements about these matters. You should read the cautionary statements made below as being applicable to all forward-looking statements wherever they appear in this document.

Business

History

Security Devices International Inc. was incorporated on March 1, 2005. The Company began as a research and development company focused on the development of 40mm less-lethal ammunition. The term 40mm refers to the diameter of the bullet (sometimes also referred to as a round or a projectile) and bullets of this size are required for standard issue military riot guns. 40mm bullets are also the emerging standard among riot guns used by police forces and correctional services, although many police forces are currently using 37mm riot guns.

The Company began with development of a wireless electric projectile (a “WEP”), named the Lektrox. The Company hired Elad Engineering Ltd. (“Elad”) a ballistics engineering firm located in Tel Aviv, Israel, to collaborate in the development of the WEP. The WEP uses mini-harpoons to fix the bullet to the target's clothing or body. The bullet contains an electrical system that releases a charge that imitates the electro-neural impulses used by the human body. Sending out a control signal to the muscles, this high-voltage low-current pulse overrides the target's nervous system inducing a muscle spasm that causes the target to fall to the ground helpless.

Commencing in December 2008, the Joint Non-Lethal Weapons Directorate (“JNLWD”) of the US Department of Defense, an organization responsible for the development and coordination of non-lethal weapons activities within the United States, tested the WEP through its evaluation facility at Penn State University. The testing evaluated the effectiveness and safety of the electrical output compared to the Government’s standard total body effects model. Testing was completed in November 2009 and a report was prepared by Penn State University and submitted to the JNLWD in January 2010. An executive summary was released to the Company indicating a positive outcome. Research and development continued on the WEP until mid-2010.

To reduce kinetic energy levels, the head of the WEP contains a cushioning mechanism composed of a collapsible material that enlarges the contact surface and absorbs part of the impact. In June 2010, the Company began development of a 40mm blunt impact projectile (the “BIP”) which used the cushioning mechanism of the WEP but did not contain the electrical mechanism of the WEP. The BIP used the pain of impact to obtain compliance from the target.

In the fall of 2010 the Company underwent a change in the board of directors and management. Two new directors were appointed and the board of directors appointed a Chief Operating Officer. The Company contracted with Level 4 Capital Corp. to assist with restructuring of the Company, contract negotiations and operational issues.

Early in 2011 the Company decided to focus its attention on the BIP and to discontinue further development work on the WEP. The Company concluded that the cost and time required to complete development and testing of the BIP were significantly less than that required to complete development and testing of the WEP. The BIP is also less expensive to produce than the WEP, and can be sold for a lower price. The Company plans to use revenue received from BIP sales to complete the development and production line for the WEP.

Initially, the Company’s products were designed, tested and assembled in Israel. In 2011, the Company moved its engineering, intellectual property and production facilities from Tel Aviv, Israel to the operator (the “BIP Manufacturer”) of an injection molding facility outside of Boston, Massachusetts. The BIP Manufacturer has a history of manufacturing 40mm components for the military sector, and provides molding services to the medical, aerospace, petrochemical, commercial, electronics, and defense industries.

The Company attended several military tradeshows through 2011 and signed a teaming agreement with Chemring Ordnance Inc. (“Chemring”), of Perry, Florida in December 2011. The agreement gives Chemring the non-exclusive right to market and sell the BIP worldwide for a five- year term. Chemring is responsible for its costs of marketing the BIPs and BIPs sold through this arrangement will bear the Chemring brand. The Company has retained the right to market the BIP directly to military, law enforcement and government agencies outside of Chemring’s sales channels.

17 

Research and development for the BIP was completed in the summer of 2012.

In October 2012, the Company obtained an ammunition certification from Chemring which meant that the BIP satisfied the standards set by Chemring for products which it would distribute.

In November 2012, the Company obtained a United States Department of Transportation number (DOT#) required in order for the Company to ship BIP rounds.

In June 2012, the Company contracted CRT Less Lethal Inc. (“CRT”) to test the BIP. CRT is a Seattle- based company founded in 2003 with expertise in the analysis, evaluation and human effects testing of less-lethal munitions. The testing protocol included accuracy, precision, consistency, muzzle and target energy, impact energy density and effective range of the BIP. Human volunteers were used during the test firing, revealing full effects to the lower body from the blunt trauma of the BIP. Extensive wound profiling from the tests were finalized in a detailed report from CRT. Based on data obtained from the three-stage evaluation, the BIP passed the CRT testing protocol for accuracy, consistency, relative safety and effectiveness.

In July 2012, the Company signed a five-year development, supply and manufacturing agreement with the BIP Manufacturer. An engineering team is available to the Company through the BIP Manufacturer for development of all of the core components of the BIP and any product changes that are necessary.

During 2012, the Company attended several law enforcement tradeshows and conducted live fire demonstrations with government agencies in Canada, and the US. Live fire demonstrations allow the Company to demonstrate the short and long distance firing capabilities, accuracy and relative safety of the BIP.

The Company has begun the development of five new less-lethal ammunition rounds. These new rounds will be a modified version of the BIP, four of which will carry a payload (a marking liquid, a marking powder, pepper spray and a pungent odor) and the fifth of which is a lower cost practice round. SDI expects to complete development of these five new ammunition rounds by the fourth quarter of calendar 2013. The Company has now moved into the testing phase with the payload rounds.

Products

SDI’s business is the development, manufacture and sale of less-lethal ammunition. This ammunition is used by the military and police forces for crowd control.

The Company has two products:

a)	The Company has developed the BIP, a blunt impact projectile which uses pain to control a target. The Company is developing five versions of the standard BIP, four of which contain a payload and one of which is a cheaper cost practice round. A payload is an internal capsule inside the BIP, which holds a liquid or powder substance.
b)	The Company has undertaken substantial work to develop the WEP, a wireless electric projective which releases an electrical pulse that induces a muscle spasm and causes the target to fall to the ground helpless.

Less-Lethal Sector

Both military and law enforcement agencies are seeking alternatives to traditional lethal ammunition. From a military standpoint, the involvement of armed forces in populated areas has created a need for less-lethal ammunition. Police forces also require non-lethal ammunition for riot control and critical incident de-escalation, motivated in part by a desire to avoid expensive litigation.

18

Chemical irritants (such as tear gas) have been sporadically used by military and have been adopted by police forces around the world for use in riot control.

Throughout the 1970’s and 1980’s the military and police forces began to use kinetic energy impact projectiles. These projectiles included wood, rubber and bean-bag material as ammunition. Many of these projectiles are still being used by military and police forces around the world. There has been very little technology progression within this space over the last half a century.

The rubber bullet was developed by the Ministry of Defense for the British Army in Northern Ireland at the request of army officers who wanted a weapon for use in civil disturbances with a range beyond a stone-throwing distance. In management’s opinion, rubber bullets are inaccurate and have unpredictable ricochets. In addition, management believes that they have caused numerous severe injuries and several deaths.

The nature of a military’s role has changed significantly to the extent that the military becomes actively engaged in the policing of civilian populations. This is where the military in effect, intersects with local police forces to support and uphold national and regional law. Today, military units are involved in on-going conflicts that bring them into direct contact with civilian populations in Iraq, Afghanistan and various countries in the Middle East. Soldiers who are deployed in humanitarian roles are often subject to rules of engagement which disallow the use of deadly force unless soldiers encounter a lethal threat. The military requires less-lethal deterrent ammunition for use in crowd and riot control, perimeter security and pilfering situations. In management’s opinion, less-lethal ammunition means a greater opportunity to preserve life.

Police and military forces require easily applied options for riot control without the consequences of lethal force. In addition to the litigation, administrative and financial resources required to defend the use of lethal force, there is a moral consideration as well. Police and military forces must balance the risk of injury or death to their own personnel against the risk of injury to civilians, including bystanders. Riot control involves difficult and challenging decision that often must be made within seconds.

Both police and military personnel are demanding access to options that fall somewhere between physically charging into a crowd with batons and firing munitions designed to kill targets. If these personnel are equipped and trained with less-lethal munitions, they are better equipped to diffuse a riot and regain control. By providing soldiers and police with a midlevel force response, appropriate to the level of threat, the chance of an escalation can be reduced. In addition, if this less-lethal response can be employed at a standoff distance, the troops or officers can maintain a buffer zone between themselves and the crowd. The capability to target a specific individual, as opposed to spraying an entire crowd, reduces the risk of injury to innocent bystanders and political backlash.

Conflicts in Iraq and Afghanistan, events such as the August 2011 UK riots, and the June 2012 Quebec student street violence have led governments, police and defense decision-makers to seek cost effective less-lethal weapons. These decision-makers understand that social media will limit the use of lethal weapons and a new generation of less-lethal weapons is required.

Significant Events

During the quarter the Company completed the following events:

• the Company was given conditional approval from the Ontario Securities Commission (OSC) for a public offering
• the Company filed its amended and restated prospectus with the OSC and TSX Venture Exchange
• the Company completed its Initial Public Offering on the TSX Venture Exchange, raising a gross proceeds of CDN $3,993,980.

19

Going Concern

These unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year The Company is in the development stage and has not yet realized revenues from its planned operations. The Company has incurred a cumulative loss of $20,773,151 from inception to August 31, 2013 which includes a non-cash stock based compensation expense of $6,585,016 for issue of options and warrants. The Company has funded operations through the issuance of capital stock and convertible debentures.

In addition to raising funds in the prior years, the Company raised $160,000 through the issuance of 800,000 common shares during the year ended November 30, 2011. The Company further raised an additional $878,328 by issue of Convertible Debentures during the year ended November 30, 2011 and $910,000 during the year ended November 30, 2012. In addition, the Company raised $649,750 by issuance of 2,165,834 common shares during the year ended November 30, 2012. On August 15, 2013, the Company filed an amended and restated final prospectus (the “Prospectus”) in Canada, in the provinces of Alberta, British Columbia and Ontario for listing its shares in these provinces in Canada. On August 27, 2013 the Company completed an initial public offering to raise gross proceeds of CDN $3,993,980 (US $3,794,280) through the issuance of 9,984,950 Common Shares at a price of CDN$0.40 (US $0.38) per Common Share (the “Issue Price”). The Company’s common shares commenced trading on the TSX Venture Exchange (“TSX”) under the symbol “SDZ”.

While the Company has been successful in securing financings in the past, there is no assurance that it will be able to do so in the future. Accordingly, these financial statements do not give effect to adjustments, if any, that would be necessary should the Company be unable to continue as a going concern.

At August 31, 2013, the Company had an accumulated deficit during the development stage of $20,773,151 which includes a non-cash stock based compensation expense of $6,585,016 for issue of options and warrants.

Significant Quarterly Information

The following represents selected information of the Company for the most recently completed financial quarter ended August 31, 2013

	Three- month period	Three- month period
	August 31, 2013	August 31 , 2012
	(unaudited)	(unaudited)
	$	$
Net loss for the three month period	444,595	350,630
Basic and diluted loss per share	0.01	0.01

	As at	As at
	August 31, 2013	November 30, 2012
Total assets	3,064,858	417,219
Total liabilities	960,546	1,343,007
Cash dividends per share	-	-

20

Results of Operations

SDI was incorporated on March 1, 2005 and for the period from inception to August 31, 2013 has not generated any revenue.

Financial highlights (unaudited) for the three month and nine month period ending August 31, 2013 with comparatives are as follows:

Operating Results	For the three months ended August 31,	For the three months ended August 31 ,
	2013	2012
Operating Expenses	$387,676	$313,096
Other expenses - Interest	$56,919	$37,534
Net Loss for Period	$444,595	$350,630
(Loss) per Share	($0.01)	($0.01)

Operating Results	For the nine months ended August 31,	For the nine months ended August 31 ,
	2013	2012
Operating Expenses	$1,332,765	$824,559
Other expenses - Interest	$144,240	$126,711
Net Loss for Period	$1,477,005	$951,270
(Loss) per Share	($0.04)	($0.04)

The Company’s selected information for the nine month period ended August 31, 2013 (unaudited) and November 30, 2012 (audited) are as follows:

	August 31, 2013	November 30, 2012
Total current assets	2,902,246	272,171
Total assets	3,064,858	417,219
Total current liabilities	960,546	150,368
Convertible debentures	-	1,192,639
Total liabilities	960,546	1,343,007
Stockholders’ equity (deficiency)	2,104,312	(925,788)

Net loss for the nine months ended August 31, 2013 was $1,477,005 ($0.04 per share) as compared to $951,270 ($0.04 per share) for the nine month period ended August 31 , 2012. The major variance in net loss for the nine months in 2013 as compared with 2012 is attributable to the following:

21

(i)	Increase in legal and consulting expenses in 2013 as compared to 2012
(ii)	Stock based compensation expense $99,245 in 2013 as compared to $213,440 in 2012
(iii)	Credit (recovery) of $nil in 2013 as compared to $215,143 in 2012 for research and product development

The major components of change for (i) relate to:

(a) Effective January 1, 2013, SDI executed an agreement with a consultant to pay compensation of $7,000 per month. The consultant is to assist with sales initiatives, demos and participate in trade shows. The agreement is for a period of one year. The Company expensed $56,000 during the nine month period ended August 31, 2013 and $nil during the nine month period ended August 31, 2012.

(b) Effective January 1, 2013, SDI executed an agreement with another consultant to pay compensation of $7,000 per month. The consultant is to assist with sales initiatives, demos and participate in trade shows. The agreement is for a period of one year. The Company expensed $56,000 during the nine month period ended August 31, 2013 and $nil during the nine month period ended August 31, 2012.

(c) The Company filed a prospectus in Canada and an S-1 registration statement in the USA to raise funds as per the prospectus. The Company has incurred additional legal and other general and administrative expenses in 2013 as compared to $nil in 2012.

The major components of change for (ii) relate to:

a) During the nine month period ended August 31, 2013, the board of directors granted 325,000 warrants to various lenders (includes 50,000 warrants to a director) who provided a working capital loan of $628,550 (CAD $650,000). These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. The fair value of the warrants issued for the purpose of estimating the stock compensation was calculated using the Black-Scholes option pricing model at $99,245.

b) During the nine month period ended August 31, 2012, the board of directors granted options to three directors to acquire a total of 775,000 common shares, one officer to acquire 20,000 common shares and two consultants to acquire a total of 110,000 common shares. The 905,000 options were issued at an exercise price of $0.13 per share and vest immediately with an expiry term of four years. The fair value of the options issued for the purpose of estimating the stock compensation was calculated using the Black-Scholes option pricing model at $113,292.

c) During the nine month period ended August 31, 2012, the board of directors issued warrants to a Company in which the Chief Operating officer has an interest in, to acquire a total of 800,000 common shares. These warrants were issued at an exercise price of $0.13 per share with an expiry term of four years. The fair value of the options issued for the purpose of estimating the stock compensation was calculated using the Black-Scholes option pricing model at $100,148.

The major components of change for (iii) relate to:

On November 30, 2009, the Company entered into a Memorandum of Understanding (“MOU”) with its former research and development services contractor Elad Engineering Ltd. (“Elad’) to settle their liability. On March 13, 2012, the Company entered into a definitive agreement with Elad to settle the accounts payable. Elad had previously performed services for the development of a less-than-lethal-electric-projectile and blunt impact projectile. At the date of the settlement agreement, the Company owed Elad $315,143.The Company and Elad agreed to irrevocably waive and release each other from any claim, demand or action in connection with services provided, upon payment of $100,000 by the Company to Elad no later than March 20, 2012. The $100,000 payment was made on March 20, 2012. The Company recorded the reduction of the payable in the amount of $215,143 during the period ended May 31, 2012 as recovery of research and development product development cost. This was measured as the difference between the amount payable to Elad and the settlement amount.

22

Cash Flows

Net cash used in operations for the nine months ended August 31, 2013, was $956,040 as compared to $881,786 used for the nine months ended August 31, 2012. The major components of change relate to:

1) Items not affecting cash:

Stock based compensation of $99,245 in 2013, as compared to $213,440 in 2012.

a) During the nine month period ended August 31, 2013, the board of directors granted 325,000 warrants to various lenders (includes 50,000 warrants to a director) who provided a working capital loan of $628,550 (CAD $650,000). These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. The fair value of the warrants issued for the purpose of estimating the stock compensation was calculated using the Black-Scholes option pricing model at $99,245.

b) During the nine month period ended August 31, 2012, the board of directors granted options to three directors to acquire a total of 775,000 common shares, one officer to acquire 20,000 common shares and two consultants to acquire a total of 110,000 common shares. The 905,000 options were issued at an exercise price of $0.13 per share and vest immediately with an expiry term of four years. The fair value of the options issued for the purpose of estimating the stock compensation was calculated using the Black-Scholes option pricing model at $113,292.

c) During the nine month period ended August 31, 2012, the board of directors issued warrants to a Company in which the Chief Operating officer has an interest in, to acquire a total of 800,000 common shares. These warrants were issued at an exercise price of $0.13 per share with an expiry term of four years. The fair value of the options issued for the purpose of estimating the stock compensation was calculated using the Black-Scholes option pricing model at $100,148.

Recovery of accounts payable for nil in 2013 as compared to $(215,143) in 2012

On November 30, 2009, the Company entered into a Memorandum of Understanding (“MOU”) with its former research and development services contractor Elad Engineering Ltd. (“Elad’) to settle their liability. On March 13, 2012, the Company entered into a definitive agreement with Elad to settle the accounts payable. Elad had previously performed services for the development of a less-than-lethal-electric-projectile and blunt impact projectile. At the date of the settlement agreement, the Company owed Elad $315,143.The Company and Elad agreed to irrevocably waive and release each other from any claim, demand or action in connection with services provided, upon payment of $100,000 by the Company to Elad no later than March 20, 2012. The $100,000 payment was made on March 20, 2012. The Company recorded the reduction of the payable in the amount of $215,143 during the period ended February 29, 2012 as recovery of research and development product development cost. This was measured as the difference between the amount payable to Elad and the settlement amount.

Net cash flow from investing activities was $45,219 during the nine month period ended August 31, 2013 as compared to $ 147,219 for the same period for prior year.

Net Cash flow from financing activities was an inflow of $522,335 being loans from non-related parties and $94,970 being a loan from related party during the nine months period ended August 31, 2013 ( $nil in August 31, 2012). The Company obtained unsecured loans for general working capital purposes (“Working Capital Loans”). The Working Capital Loan proceeds will be used for general working capital purposes and the Working Capital Loans, together with interest at 6% per annum, accrued and calculated daily, plus $39,000 will be repaid on the earlier of July 30, 2013 and demand.

On August 27, 2013, the Company completed an initial public offering to raise gross proceeds of $3,794,280 (CAD $3,993,980) through the issuance of 9,984,950 Common Shares at a price of $0.38 (CDN$0.40) per Common Share (the “Issue Price”). The company incurred expenses of $734,565 to raise the capital which included a fee of CAD $80,000 paid to a former director and CEO in accordance with the terms of an agreement regarding escrow of shares and a cash commission of CDN$359,458 paid to the Agent During the period ended August 31, 2012, the Company raised $910,000 by issue of Convertible Debentures and $400,000 by issue of common shares

There was an overall increase in cash of $2,655,746 in 2013 as compared to an increase of $280,995 during 2012.

23

Liquidity and Capital Resources

As at August 31, 2013, cash was $2,888,217, as compared to $232,471 at November 30, 2012. This increase is mainly attributable to the combination of factors mentioned above under heading “Cash Flows”.

At August 31, 2013, the Company had a working capital of $1,941,700. The major components are as follows; cash $2,888,217; prepaid expenses and other receivables $14,029;accounts payable and accrued liabilities of $343,241; loan from non- related parties for $522,335 and loan from related party for $94,970. On August 27, 2013, the Company completed an initial public offering to raise gross proceeds of $3,794,280 (CAD $3,993,980) through the issuance of 9,984,950 Common Shares at a price of $0.38 (CDN$0.40) per Common Share (the “Issue Price”).

At November 30, 2012, the Company had a working capital of $121,803. The major components are as follows; cash $232,471; prepaid expenses and other receivables $7,200; deferred costs for $32,500 and accounts payable and accrued liabilities of $150,368

During the period from inception (March 1, 2005) through August 31, 2013, SDI’s operations used $12,842,305 in cash. During this period SDI purchased $251,211 of equipment and raised $15,981,733 from financing activities. There are no assurances that the Company can continue to raise equity financing to fund its operations. SDI does not have any commitments or arrangements from any persons to provide SDI with any additional capital it may need.

24

Off-balance sheet arrangements

The Company has no significant off-balance sheet arrangements at this time.

Transactions with related parties

Nine months ended August 31, 2013

The directors were compensated as per their consulting agreements with the Company. The Company expensed a total of $233,400 as management fees to its three directors and expensed a total of $5,400 as automobile allowance.

The Company expensed $34,730 for services provided by the CFO of the Company and $180,000 for services provided by a corporation in which the Chief Operating Officer has an interest.

The Company reimbursed $92,735 to directors and officers for travel and entertainment expenses incurred for the Company.

On March 4, the board of directors granted 100,000 warrants as an incentive to a director who provided a working capital loan of $94,970 (CAD $100,000). These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. The Company expensed $15,637 as compensation expense. In addition the Company has accrued interest of $8,811 till August 31, 2013.

Nine months ended August 31, 2012

The directors were compensated as per their consulting agreements with the Company. The Company expensed a total of $198,000 as Management fees for payment to its three directors and expensed a total of $4,800 as automobile allowance.

On January 4, 2012, the board of directors granted options to three directors to acquire a total of 775,000 common shares and one officer to acquire 20,000 common shares. All these 795,000 options were issued at an exercise price of $0.13 per share and vest immediately with an expiry term of four years. The Company expensed stock based compensation cost of $99,522 for these options.

On January 4, 2012, the board of directors issued warrants to a Company in which the Chief Operating officer has an interest in, to acquire a total of 800,000 common shares. These warrants were issued at an exercise price of $0.13 per share with an expiry term of four years. The Company expensed stock based compensation cost of $100,148.

On August 9, 2012, the board of directors issued warrants to a Company owned and controlled by a director, to acquire a total of 400,000 common shares. These warrants were issued at an exercise price of $0.20 per share with an expiry term of four years. The Company expensed stock based compensation cost of $75,013.

The Company expensed $18,050 for services provided by the CFO of the Company and $151,600 for services provided by a Company in which the Chief Operating Officer has an interest.

25

Commitments

a) Consulting agreements:

The directors of the Company executed consulting agreements with the Company on the following terms:

Effective January 1, 2013, SDI executed an agreement with a Company in which a director Allan Ezer has an interest in, for a period of two years to pay compensation of $8,500 per month with a 5% increase on the first anniversary date for services rendered. Either party may terminate the consulting agreement by giving 30 days written notice.

Agreement with the Chief Executive Officer Greg Sullivan to pay compensation of $12,000 per month, with an annual 5% increase and a car allowance of $600 per month. The agreement expires December 31, 2016. The monthly remuneration will increase with accomplishment of milestones. The agreement may be terminated with mutual consent or by the Chief Executive Officer giving three weeks notice.

Effective October 4, 2012, SDI executed an agreement with a Company in which the Chief Operating Officer Dean Thrasher has an interest in, for a period of two years which expires September 30, 2014 for services rendered. The total consulting fees are estimated at $480,000 for the two year period. The Company expensed $180,000 during the nine month period ended August 31, 2013. The Company may also accept common shares at $0.45 per common share in lieu of cash. As of August 31, 2013, the Company has not exercised its right to accept this compensation in shares.

SDI entered into an agreement (the “Teaming Agreement”) dated November 30, 2011 with Chemring Ordnance, Inc. (“Chemring”) pursuant to which both agreed to establish a co-operative and supportive team to develop the best marketing, management and technical approach for the worldwide manufacture and sale of 40mm less that blunt trauma ammunition. The Teaming Agreement provides for SDI and Chemring to create a team for the purpose of preparing competitive, cost effective proposals in response to requests for proposals and obtaining and performing any contracts that result therefrom.

Pursuant to the Teaming Agreement, if a contract is awarded, each of SDI and Chemring will perform the work to be done by it as specified in the Teaming Agreement and will share the revenue as set out in the Teaming Agreement. Either party who initiated the proposal that led to the contract will be the prime contact for that customer. Upon a contract being awarded to either SDI or Chemring, it will subcontract with the other for the other’s share of the work. In accordance with the Teaming Agreement, the BIP ammunition sold will have Chemring’s branding unless otherwise agreed by the parties.

The Teaming Agreement will terminate on December 20, 2016. The Teaming Agreement may also expire if a time period of two years from the effective date of the agreement passes without a bona fide arms length contract being executed and delivered with respect to BIP ammunition. It will also terminate if either party is in material breach of the Agreement or a subcontract that hasn’t been resolved, if any required governmental licenses or approvals or permits are revoked, in the event of a debarment or suspension of a party at the option of the other party, and by the mutual written agreement of the parties.

The Company entered into a Development, Supply and Manufacturing Agreement with the BIP Manufacturer on July 25, 2012. This Agreement provides the Company to order and purchase only from the BIP Manufacturer certain 40MM assemblies and components for use by the Company to produce less-lethal and training projectiles as described in the Agreement. The Agreement is for a term of five years with an automatic extension for an additional year if neither party has given written notice of termination prior to the end of the five year period.

Effective January 1, 2013, SDI executed an agreement with a non-related consultant to pay compensation of $7,000 per month. The consultant is to assist with sales initiatives, demos and participate in trade shows. The agreement is for a period of one year. Either party may terminate the consulting agreement by giving 30 days written notice.

Effective January 1, 2013, SDI executed an agreement with another non-related consultant to pay compensation of $7,000 per month. The consultant is to assist with sales initiatives, demos and participate in trade shows. The agreement is for a period of one year. Either party may terminate the consulting agreement by giving 30 days written notice.

b) The Company has commitments for leasing office premises in Oakville, Ontario, Canada to April 30, 2018 at a monthly rent of Canadian $6,399 per month.

Subsequent event

a)	Subsequent to the quarter, the holder of a bridge loan exercised the holder’s right to convert the principal and interest (totaling CAD$382,014) into common shares at CAD$0.30 per share, resulting in the issuance of 1,273,378 common shares.
b)	Subsequent to the quarter, the loan from related party for $94,970 (CAD$100,000) and loan from unrelated party for $189,940 (CAD $200,000) was repaid along with interest.

Revenue Recognition

The Company’s revenue recognition policies are expected to follow common practice in the manufacturing industry. The Company will record revenue when it is realized, or realizable and earned. The Company considers revenue to be realized, or realizable and earned, when the following revenue recognition requirements will be met: persuasive evidence of an arrangement exists; the products or services have been accepted by the customer via delivery or installation acceptance; the sales price is fixed or determinable; and collectability is probable. For product sales, the Company determines that the earnings process is complete when title, risk of loss and the right to use equipment has transferred to the customer.

Outstanding share data

As of October 15, 2013, the Company had 46,952,532 issued and outstanding shares of common stock

26

Risk Factors

We may not successfully commercialize any of our products or earn a profit.

We have incurred losses since incorporation. As of August 31, 2013, we have an accumulated total deficit of $20,773,151. To date, we have experienced negative cash flow from development of our products. We currently have not generated any revenue from operations and expect to incur substantial net losses for the foreseeable future to further develop and commercialize our products. We cannot predict the extent of these future net losses, or when we may attain profitability, if at all. If we are unable to generate significant revenue from our products or attain profitability, we will not be able to sustain operations.

Because of the numerous risks and uncertainties associated with developing and commercializing our products, we are unable to predict the extent of any future losses or when we will become profitable, if ever. We may never become profitable and you may never receive a return on an investment in our common stock. An investor in our common stock must carefully consider the substantial challenges, risks and uncertainties inherent in a developmental stage company. The Common Shares must be considered highly speculative due to the nature of the Company’s business, the early stage of its deployment, its current financial position and ongoing requirements for capital. An investment in the Common Shares should only be considered by those persons who can afford a total loss of investment, and is not suited to those investors who may need to dispose of their investment in a timely fashion. We may never successfully commercialize our products, and our business may fail. Investors should consult with their own professional advisors to assess the legal, financial and other aspects of an investment in Common Shares.

We need substantial additional capital to grow and fund our present and planned business and business strategy.

We anticipate expending substantial funds to carry out the development, introduction and manufacture of additional products. We have no source of operating cash flow to fund all of its operational needs and will require additional financing to continue its operations. As such, our current and planned operations contemplate funding in the future through one or more public or private equity financings, by taking on debt financing, or from other sources. There can be no assurance that such financing will be available on favorable terms or at all. If such funds are unavailable or are only available at a prohibitive cost, we may have to significantly curtail its product development program or seek funds through financing alternatives that may require us to sell its rights to certain products or certain marketing territories. Failure to meet funding milestones may have a significant adverse effect on our growth and we may have to curtail our business strategy. Failure to obtain such additional financing could result in delay or indefinite postponement of the deployment of our products. If we receive less funding than planned, we will have to revise our business model and reduce proposed plans. Without significant funding, we will not be able to execute on our business operations and may be forced to cease operations. At this time, there can be no assurance we will be able to obtain the funding we need and even if we obtain such funding that it will be on terms and conditions favorable to us and our existing shareholders. Without funding we will not be able to proceed with planned operations or meet existing obligations.

27

There is substantial doubt as to our ability to continue as a going concern.

Due to our recurring losses from operations, there is substantial doubt about our ability to continue as a going concern, meaning that we may not be able to continue in operation for the foreseeable future or be able to realize assets and discharge liabilities in the ordinary course of operations. Our audited financial statements for the year ended November 30, 2012 were prepared assuming that we will continue as a going concern. However, the report of our independent registered public accounting firm stated there was substantial doubt about our ability to continue as a going concern. Such an opinion could materially limit our ability to raise additional funds through the issuance of new debt or equity securities or otherwise. There is no assurance that sufficient financing will be available when needed to allow us to continue as a going concern. The perception that we may not be able to continue as a going concern may cause others to choose not to deal with us due to concerns about our ability to meet our contractual obligations.

There can be no assurance that we can generate substantial revenue growth, or that any revenue growth that is achieved can be sustained.

Revenue growth that we have achieved or may achieve may not be indicative of future operating results. In addition, we may increase further its operating expenses in order to fund higher levels of research and development, increase its sales and marketing efforts and increase its administrative resources in anticipation of future growth. To the extent that increases in such expenses precede or are not subsequently followed by increased revenues, the Company’s business, operating results and financial condition will be materially adversely affected.

We are dependent on certain members of our management.

The loss of the services of one or more of them could adversely affect us. Our ability to maintain its competitive position is dependent upon its ability to attract and retain highly qualified managerial, specialized technical, manufacturing, sales and marketing personnel. There can be no assurance that we will be able to continue to recruit and retain such personnel. Our inability to recruit and retain such personnel would adversely affect our operations and product development.

We are dependent on key suppliers

We purchase certain key components of its products from a limited number of key suppliers. Failure of a supplier to provide sufficient quantities on favorable terms or on a timely basis could result in possible lost sales.

We may be subject to product or warranty claims that could have a material adverse effect on our business, operating results and financial condition.

We may be subject to proceedings or claims that may arise in the ordinary conduct of the business, which could include product and service warranty claims, which could be substantial. If our products fail to perform as warranted and we fail to quickly resolve product quality or performance issues in a timely manner, sales may be lost and we may be forced to pay damages. Any failure to meet customer requirements could materially affect our business, results of operations and financial condition. The occurrence of product defects and the inability to correct errors could result in the delay or loss of market acceptance of our products, material warranty expense, diversion of technological and other resources from our product development efforts, and the loss of credibility with customers, manufacturer’s representatives, distributors, value added resellers, systems integrators, original equipment manufacturers and end-users, any of which could have a material adverse effect on our business, operating results and financial condition.

We currently have general liability insurance, which includes product liability coverage. There is no assurance this insurance policy will cover all potential claims which may have a material adverse effect on the business or financial condition of the Company. A product recall could have a material adverse effect on our business or financial condition.

28

We rely upon, and expect to rely upon, strategic alliances with original equipment manufacturers for the manufacturing and distribution of its products.

There can be no assurance that such strategic alliances can be achieved or that the Company will be able to maintain existing strategic alliances or that we will achieve our goals.

In order to commercialize its technology, we must either acquire or develop an internal marketing and sales force with technical expertise and supporting distribution capabilities or arrange for third parties to perform these services.

In order to market any of our products, we must either acquire or develop a sales and distribution infrastructure. The acquisition or development of a sales and distribution infrastructure would require substantial resources, which may divert the attention of our management and key personnel, and defer our product development and deployment efforts. To the extent that we into marketing and sales arrangements with other companies, our revenues will depend on the efforts of others. These efforts may not be successful. If we fail to develop substantial sales, marketing and distribution channels, or to enter into arrangements with third parties for those purposes, we will experience delays in product sales and incur increased costs, which may affect our business, operating results and financial condition.

The markets for our products and services are characterized by rapidly changing technology and evolving industry standards, which could result in product obsolescence or short product life cycles.

Accordingly, our success is dependent upon its ability to anticipate technological changes in the industries it serves and to successfully identify, obtain, develop and market new products that satisfy evolving industry requirements.

There can be no assurance that we will successfully develop new products or enhance and improve its existing products or that any new products and enhanced and improved existing products will achieve market acceptance. Further, there can be no assurance that competitors will not market products that have perceived advantages over the our products or which render the products currently sold by us obsolete or less marketable.

We must commit significant resources to developing new products before knowing whether its investments will result in products the market will accept. To remain competitive, we may be required to invest significantly greater resources then currently anticipated in research and development and product enhancement efforts, and result in increased operating expenses. There can be no assurance that we will have adequate capital to meet these demands.

Our industry is highly competitive and composed of many domestic and foreign companies.

We have experienced and expect to continue to experience, substantial competition from numerous competitors with greater resources and whom we expect to continue to improve their products and technologies. Competitors may announce and introduce new products, services or enhancements that better meet the needs of end-users or changing industry standards, or achieve greater market acceptance due to pricing, sales channels or other factors. Competitors may be able to respond more quickly than we can to changes in end-user requirements and devote greater resources to the enhancement, promotion and sale of their products.

We are materially dependent on acceptance of our products by the law enforcement, both domestic and international, and federal markets. If law enforcement agencies choose not to purchase our products, our revenues will be adversely affected.

A substantial number of law enforcement and corrections agencies may not purchase our products. Law enforcement and corrections agencies may be influenced by claims or perceptions that WEPs and BIPs (each as hereinafter defined), such as our products, are unsafe or may be used in an abusive manner. Sales of our products to these agencies may also be delayed or limited by these claims or perceptions.

Most of our end-user customers are subject to budgetary and political constraints, particularly in the currently challenging economic environment, that may delay or prevent sales.

Most of our end-user customers are government agencies. These agencies often do not set their own budgets and therefore, have limited control over the amount of money they can spend. In addition, these agencies experience political pressure that may dictate the manner in which they spend money. As a result, even if an agency wants to acquire our products, it may be unable to purchase them due to budgetary or political constraints. Currently, many governmental agencies are continuing to experience severe budgetary constraints. There can be no assurance that the economic and budgeting issues will not worsen and adversely impact sales of our products. Some government agency orders may also be canceled or substantially delayed due to budgetary, political or other scheduling delays which frequently occur in connection with the acquisition of products by such agencies and such cancellations may accelerate or be more severe than we have experienced historically as a result of the current economic environment.

We may face personal injury, wrongful death and other liability claims that harm our reputation and adversely affect our sales and financial condition.

Our products can be used in aggressive confrontations that may result in serious, permanent bodily injury or death to those involved. Our products may be associated with these injuries. A person injured in a confrontation or otherwise in connection with the use of our products may bring legal action against us to recover damages on the basis of theories including personal injury, wrongful death, negligent design, defective product or inadequate warning. We are currently subject to a number of such lawsuits. We may also be subject to lawsuits involving allegations of misuse of our products. If successful, personal injury, misuse and other claims could have a material adverse effect on our operating results and financial condition and could result in negative publicity about our products. Although we carry product liability insurance, we do incur significant legal expenses within our self-insured retention in defending these lawsuits and significant litigation could also result in a diversion of management’s attention and resources, negative publicity and a potential award of monetary damages in excess of our insurance coverage. The outcome of any litigation is inherently uncertain and there can be no assurance that our existing or any future litigation will not have a material adverse effect on our revenues, our financial condition or financial results.

29

We face risks associated with rapid technological change and new competing products.

The technology associated with law enforcement devices is receiving significant attention and is rapidly evolving. While we have patent protection in key areas of our technology, it is possible that new technology may result in competing products that operate outside our patents and could present significant competition for our products.

We are subject to numerous and health and safety laws and regulations, which may require us to make substantial expenditures.

We are subject to numerous federal, state, local and foreign health and safety legislation and measures relating to the manufacture of ammunition. There can be no assurance that we will not experience difficulties with our efforts to comply with applicable regulations as they change in the future or that our continued compliance efforts (or failure to comply with applicable requirements) will not have a material adverse effect on our results of operations, business, prospects and financial condition. Our continued compliance with present and changing future laws could restrict our ability to modify or expand our facilities or continue production and could require us to acquire costly equipment or to incur other significant expense.

Health and safety and violations related to our products may arise that could lead to litigation or other action against us or to regulation of certain of our product components. We may also incur substantial penalties, civil and criminal sanctions, permit revocations and facility shutdowns. We may be required to modify our technology and may not be able to do so. We may also be required to pay damages that may reduce our profitability and adversely affect our financial condition. Additionally, future and health and safety laws and regulations or reinterpretation of current laws and regulations may require us to make substantial expenditures. Even if these concerns prove to be baseless, the resulting negative publicity could affect our ability to market our products. In turn, our costs to comply with, or any liabilities under, these laws and regulations could have a material adverse effect on our business, financial condition, cash flows and results of operations.

We may be unable to adequately protect or enforce our patents and proprietary rights.

Our future success depends, in part, on our ability to protect our intellectual property and maintain the proprietary nature of our technology through a combination of patents, licenses and other intellectual property arrangements, without infringing the proprietary rights of third parties. Although we consider certain of our product designs as well as manufacturing processes involving certain of its products to be proprietary, patents or copyrights do not protect all design and manufacturing processes. We have adopted procedures to protect its intellectual property and maintain secrecy of its confidential business information and trade secrets. However, there can be no assurance that such procedures will afford complete protection of such intellectual property, confidential business information and trade secrets. There can be no assurance that our competitors will not independently develop technologies that are substantially equivalent or superior to our technology.

We currently have 3 patents relating to our business and 1 patent pending. We cannot assure you that these pending patents will be issued or that any of our patents will be held valid if challenged, that any pending patent applications will issue, or that other parties will not claim rights in or ownership of our patents and other proprietary rights. Moreover, patents issued to us may be circumvented or fail to provide adequate protection. Our competitors might independently develop or patent technologies that are substantially equivalent or superior to our technologies. Since patent applications in the United States are not publicly disclosed until the patent is issued, applications may have been filed by others which, if issued as patents, could cover our products. We cannot be certain that others will not assert patent infringement claims or claims of misappropriation against us based on current or pending U.S. and/or foreign patents or trade secrets or that such claims will not be successful.

We also rely on trade secrets to develop and maintain our competitive position. Although we protect our proprietary technology in part by confidentiality agreements with our employees, consultants and corporate partners, we cannot assure you that these agreements will not be breached, that we will have adequate remedies for any breach or that our trade secrets will not otherwise become known or be discovered independently by our competitors. The failure to protect our intellectual property rights effectively or to avoid infringing the intellectual property rights of others could seriously harm our business, financial condition and results of operations and ability to achieve sufficient cash flow to service our indebtedness.

Our commercial success depends, in part, upon us not infringing intellectual property rights of others.

While we believe that our products and other intellectual property do not infringe upon the proprietary rights of third parties, our commercial success depends, in part, upon us not infringing intellectual property rights of others. A number of our competitors and other third parties have been issued or may have filed patent applications or may obtain additional patents and proprietary rights for technologies similar to those utilized by us. Some of these patents may grant very broad protection to the owners of the patents. We have not undertaken a review to determine whether any existing third party patents or the issuance of any third party patents would require us to alter its technology, obtain licenses or cease certain activities. We may become subject to claims by third parties that its technology infringes their intellectual property rights due to the growth of products in its target markets, the overlap in functionality of those products and the prevalence of products. We may become subject to these claims either directly or through indemnities against these claims that it provides to end-users, manufacturer’s representatives, distributors, value added resellers, system integrators and original equipment manufacturers.

Litigation may be necessary to determine the scope, enforceability and validity of third party proprietary rights or to establish our proprietary rights. Some of our competitors have, or are affiliated with companies having, substantially greater resources than us and these competitors may be able to sustain the costs of complex intellectual property litigation to a greater degree and for a longer period of time than us.

In addition, defending our company against these types of claims, regardless of their merits, could require us to incur substantial costs, divert the attention of key personnel and management, cause significant delays and materially disrupt the conduct of our business. Parties making these types of claims may be able to obtain injunctive or other equitable relief which could effectively block our ability to provide our services and could result in an award of substantial damages. In the event of a successful claim of infringement, we may need or be required to obtain one or more licenses from, as well as grant one or more licenses to, others. We cannot assure you that we could obtain necessary licenses from others at a reasonable cost or at all.

Regardless of their merit, any such claims could be time consuming to evaluate and defend, result in costly litigation, cause product shipment delays or stoppages, divert key personnel and management’s attention and focus away from the business, subject us to significant liabilities and equitable remedies, including injunctions, require us to enter into costly royalty or licensing agreements and require us to modify or stop using infringing technology Parties making these types of claims may be able to effectively block our ability to manufacture our products and could result in an award of substantial damages. In the event of a successful claim of infringement, we may be prohibited from developing or commercializing certain technologies and products unless it obtains a license from a third party or we may need or be required to grant one or more licenses to, others. There can be no assurance that we will be able to obtain any such license on commercially favorable terms or at all. If we do not obtain such a license, we could be required to cease the sale of certain products.

30

We are subject to currency and foreign exchange fluctuations

Fluctuations in the exchange rate between the United States dollar and the Canadian dollar may have a material effect on the our results of operations. To date, we have not engaged in exchange rate-hedging activities. To the extent that we may seek to implement hedging techniques in the future with respect to its foreign currency transactions, there can be no assurance that we will be successful in such hedging activities.

Stress in the global financial system may adversely affect our finances and operations in ways that may be hard to predict or to defend against.

Recent events have demonstrated that businesses and industries throughout the world are very tightly connected to each other. Thus, events seemingly unrelated to us, or to its industry, may adversely affect its finances or operations in ways that are hard to predict or defend against. For example, credit contraction in financial markets may hurt our ability to access credit when it is needed or rapid changes in foreign exchange rates may adversely affect financial results. Finally, a reduction in credit, combined with reduced economic activity, may adversely affect businesses and industries that collectively constitute a significant portion of our customer base. As a result, these customers may need to reduce their purchases of our products, or there may be greater difficulty in receiving payment for the products that these customers purchase from us. Any of these events, or any other events caused by turmoil in world financial markets, may have a material adverse effect on our business, operating results, and financial condition.

Our business is subject to a number of risks and hazards including industrial accidents, labor disputes, changes in the regulatory environment.

Such occurrences could result in damage to equipment, personal injury or death, monetary losses and possible legal liability. Although we maintain liability insurance in amounts which it considers adequate, the nature of these risks is such that liabilities might exceed policy limits, the liabilities and hazards might not be insurable, or we may elect not to insure against such liabilities due to high premium costs or other reasons, in which event we could incur significant costs that could have a materially adverse effect upon its financial position.

Certain of our directors and officers are or may become associated with other companies in the same or related industries which may give rise to conflicts of interest.

Directors who have a material interest in any person who is a party to a material contract or a proposed material contract with us are required, subject to certain exceptions, to disclose that interest and generally abstain from voting on any resolution to approve the contract. In addition, the directors and the officers are required to act honestly and in good faith with a view to our best interest Our directors and officers have either other full-time employment or other business or time restrictions placed on them and accordingly, we will not be the only business enterprise of these directors and officers.

We do not expect to pay dividends.

We have not paid dividends in the past and we do not expect to declare or pay any dividends on our common stock in the foreseeable future. The declaration and payment in the future of any cash or stock dividends on the common stock will be at the discretion of our board of directors and will depend upon a variety of factors, including our ability to service our outstanding indebtedness, if any, and to pay dividends on securities ranking senior to the common stock, our future earnings, if any, capital requirements, financial condition and such other factors as our board of directors may consider to be relevant from time to time. Our earnings, if any, are expected to be retained for use in expanding our business.

Our common stock is subject to volatility.

There can be no assurance that the market price for our common stock will remain at its current level and a decrease in the market price could result in substantial losses for investors. The market price of our common stock may be significantly affected by one or more of the following factors:

• announcements or press releases relating to the industry or to our own business or prospects;
• regulatory, legislative or other developments affecting us or the industry generally;
• sales by holders of restricted securities pursuant to effective registration statements or exemptions from registration;
• actual or anticipated fluctuations in our quarterly financial and operating results;
• our failure to meet the expectations of the investment community and changes in investment community recommendations or estimates of our future operating results;
• strategic moves by our competitors, such as product announcements or acquisitions;
• litigation;
• general market conditions;
• other domestic and international macroeconomic factors unrelated to our performance; and
• additions or departures of key personnel.

There is a very limited trading market for our shares and no active trading market may develop or be sustained.

Prior to the closing of the Offering, there has been a limited public market for the shares on the OTCBB in the United States. Trading prices and volumes on the OTC Bulletin Board are thin and erratic. The price paid for each Common Share under the Offering was determined by negotiation between us and the Canadian Agent; this price may bear no relation to the price at which our Common Shares will trade in the public market subsequent to the Offering. We can not predict at what price our Common Shares will trade and there can be no assurance that an active trading market in our Common Shares will develop or be sustained.

Our common stock trades on the OTCBB in the United States. As a result, there are additional risks associated with our common stock and you may be unable to liquidate your investment in our common stock quickly. The trading market for our shares is not always liquid. The market price of our shares has ranged from a high of $0.99 and a low of $0.10 during the twelve-month period ended May 31, 2013. The volume of shares traded at any one time can be limited, and, as a result, there may not be a liquid trading market for our shares.

31

There can be no assurance that an active market for our Common Shares will be sustained.

Securities of small and mid cap companies have experienced substantial volatility in the past, often based on factors unrelated to the financial performance or prospects of the companies involved. These factors include global economic developments and market perceptions of the attractiveness of certain industries. The price per Common Share is also likely to be affected by change in our financial condition or results of operations as reflected in its quarterly filings. Other factors unrelated to our performance that may have an effect on the price of our Common Shares include the following: the extent of analytical coverage available to investors concerning our business may be limited if investment banks with research capabilities do not follow our securities; lessening in trading volume and general market interest in our securities may affect a subscriber’s ability to trade significant numbers of Common Shares, the size of our public float may limit the ability of some institutions to invest in our securities; a substantial decline in the price of our Common Shares that persists for a significant period of time could cause our securities to be delisted from an exchange, further reducing market liquidity. If an active market for our Common Shares does not continue, the liquidity of a subscriber’s investment may be limited and the price of our Common Shares may decline. If such a market does not develop, investors may lose their entire investment in our Common Shares.

Any changes in government policy may result in changes to laws affecting the sale of our products.

This may affect our ability to ship product in the future. The possibility that future governments may adopt substantially different policies, may also affect our operations. Local governments in all countries we deal with issue end user certificates to purchase or receive live ammunition from us. A change in policy may lead to a decision of these countries as to whether or not they will take possession or purchase such munitions. This may have a material adverse effect on our business, operating results, and financial condition.

Our common stock is classified as a “penny stock” under SEC Rules and Regulations, which means broker-dealers may experience difficulty in completing customer transactions and trading activity in our securities may be adversely affected.

The United States Securities and Exchange Commission (the “SEC”) has adopted Rule 15g-9 which generally defines "penny stock" to be any equity security that has a market price (as defined) less than USD$5.00 per share or an exercise price of less than $5.00 per share, subject to certain exceptions. Our shares are covered by the penny stock rules, which impose additional sales practice requirements on broker-dealers who sell to persons other than established customers and "accredited investors". The term "accredited investor" refers generally to institutions with assets in excess of USD$5,000,000 or individuals with a net worth in excess of USD$1,000,000 or annual income exceeding USD$200,000 or USD$300,000 jointly with their spouse. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document in a form prepared by the SEC, which provides information about penny stocks and the nature and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction and monthly account statements showing the market value of each penny stock held in the customer's account. The bid and offer quotations, and the broker-dealer and salesperson compensation information, must be given to the customer orally or in writing prior to effecting the transaction and must be given to the customer in writing before or with the customer's confirmation. In addition, the penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from these rules, the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser's written agreement to the transaction. These disclosure requirements may have the effect of reducing the level of trading activity in the secondary market for the stock that is subject to these penny stock rules. Consequently, these penny stock rules may affect the ability of broker-dealers to trade our shares. We believe that the penny stock rules may discourage investor interest in and limit the marketability of our shares.

Due to the substantial instability in our common stock price, you may not be able to sell your shares at a profit or at all, and as a result, any investment in our shares could be totally lost.

The public market for our common stock is very limited. As with the market for many other small companies, any market price for our shares is likely to continue to be very volatile. Our common stock has very limited volume and as a “penny stock,” many brokers will not trade in our stock limiting our stocks’ liquidity. As such it may be difficult for you to sell shares of our common stock.

A decline in the price of our common stock could affect our ability to raise further working capital and adversely impact our operations.

A prolonged decline in the price of our common stock could result in a reduction in the liquidity of our common stock and a reduction in our ability to raise capital. Because our operations have been primarily financed through the sale of equity securities, a decline in the price of our common stock could be especially detrimental to our liquidity and our continued operations. Any reduction in our ability to raise equity capital in the future would force us to default on our debt obligations and forfeit our property interests or to reallocate funds from other planned uses. Either of these would have a significant negative effect on our business plans and operations, including our ability to acquire new property interests or fund our obligations for development of our current property interests. If our stock price declines, we may not be able to raise additional capital or generate funds from operations sufficient to meet our obligations.

Legal proceedings

There are no legal proceedings involving the Company or its assets which management of the Company believes to be material to the Company, nor are any such proceedings known by the Company to be contemplated.

Item 4. Controls and Procedures.

     (a) SDI maintains a system of controls and procedures designed to ensure that information required to be disclosed in reports filed or submitted under the Securities Exchange Act of 1934, as amended (“1934 Act”), is recorded, processed, summarized and reported, within time periods specified in the SEC’s rules and forms and to ensure that information required to be disclosed by SDI in the reports that it files or submits under the 1934 Act, is accumulated and communicated to SDI’s management, including its Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure. As of August 31, 2013, SDI’s Principal Executive Officer and Principal Financial Officer evaluated the effectiveness of the design and operation of SDI’s disclosure controls and procedures. Based on that evaluation, SDI’s Principal Executive Officer and Principal Financial Officer concluded that SDI’s disclosure controls and procedures were effective.

     (b) Changes in Internal Controls. There were no changes in SDI’s internal control over financial reporting during the quarter ended August 31, 2013 that materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

32 

PART II

Item 2.        Unregistered Sales of Equity Securities and Use of Proceeds

On August 27, 2013, the Company completed an initial public offering to raise gross proceeds of $3,794,280 (CAD $3,993,980) through the issuance of 9,984,950 Common Shares at a price of $0.38 (CDN$0.40) per Common Share (the “Issue Price”). The Company filed a prospectus in Canada, in the provinces of Alberta, British Columbia and Ontario for listing its shares in these provinces in Canada and also filed an S-1 registration statement in the USA.

Item 6.        Exhibits

Exhibits

31.1	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Gregory Sullivan.
31.2	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Rakesh Malhotra.
32.1	Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for Gregory Sullivan and Rakesh Malhotra.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

SECURITY DEVICES INTERNATIONAL, INC.

Date: October 21, 2013
	By: /s/ Gregory Sullivan
	Gregory Sullivan, President
	and Principal Executive
	Officer
Date: October 21, 2013
	By: /s/ Rakesh Malhotra
	Rakesh Malhotra, Principal
	Financial and Accounting
	Officer

33

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Gregory Sullivan, certify that;

1. I have reviewed this quarterly report on Form 10-Q of Security Devices International, Inc.;

2. Based on my knowledge, this report, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

     a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

     b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

     c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

     d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

     a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

     b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

October 21, 2013

/s/ Gregory Sullivan

Gregory Sullivan,

Principal Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Rakesh Malhotra, certify that;

1. I have reviewed this quarterly report on Form 10-Q of Security Devices International, Inc.;

2. Based on my knowledge, this report, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

     a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

     b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

     c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

     d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

     a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

     b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

October 21, 2013

/s/ Rakesh Malhotra

Rakesh Malhotra,

Principal Financial Officer

EX-32.1

Exhibit 32

     In connection with the quarterly report of Security Devices International, Inc., (the “Company”) on Form 10-Q for the quarter ended August 31, 2013 as filed with the Securities and Exchange Commission (the “Report”) Gregory Sullivan, the Principal Executive Officer of the Company and Rakesh Malhotra, the Principal Financial Officer of the Company, certify pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the company.

October 21, 2013	/s/ Gregory Sullivan
	Gregory Sullivan, Principal Executive Officer
October 21, 2013	/s/ Rakesh Malhotra
	Rakesh Malhotra, Principal Financial Officer

XML

LOANS FROM NON- RELATED PARTIES

9 Months Ended

Aug. 31, 2013

LOANS FROM NON- RELATED PARTIES [Text Block]

11. LOANS FROM NON- RELATED PARTIES

On January 30, 2013, the Company obtained an unsecured loan of $189,940 (CAD $200,000) for general working capital purposes (“Working Capital Loan”). The Working Capital Loan, together with interest at 6% per annum, accrued and calculated daily, plus $12,000 will be repaid on the earlier of July 30, 2013 and demand. The Company has accrued interest of $18,805 for the nine month period ended August 31, 2013. The Company also granted 100,000 warrants to the lender as bonus consideration for the loan. These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. This loan along with interest was converted to common shares (see subsequent event note 13(a))

On April 12, 2013, the Company obtained an unsecured loan of $189,940 (CAD $200,000) for general working capital purposes (“Working Capital Loan”). The Working Capital Loan, together with interest at 6% per annum, accrued and calculated daily, plus $12,000 will be repaid on the earlier of July 30, 2013 and demand. The Company has accrued interest of $16,669 for the nine month period ended August 31, 2013. The Company also granted 100,000 warrants to the lender as bonus consideration for the loan. These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years.  This loan along with interest was repaid subsequent to the quarter (see subsequent event note 13(b))

On May 14, 2013, the Company obtained an unsecured loan of $142,455 (CAD $150,000) for general working capital purposes (“Working Capital Loan”). The Working Capital Loan, together with interest at 6% per annum, accrued and calculated daily, plus $9,000 will be repaid on the earlier of July 30, 2013 and demand. The Company has accrued interest of $11,712 for the nine month period ended August 31, 2013. The Company also granted 75,000 warrants to the lender as bonus consideration for the loan. These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. This loan along with interest was converted to common shares (see subsequent event note 13(a))

XML

Interim Statements of Operations and Comprehensive loss (USD $)	3 Months Ended		9 Months Ended		102 Months Ended
	Aug. 31, 2013	Aug. 31, 2012	Aug. 31, 2013	Aug. 31, 2012	Aug. 31, 2013
OPERATING EXPENSES:
Research and product Development cost (recovery)	$ 0	$ 0	$ 0	$ (215,143)	$ 7,473,781
Amortization	10,474	7,141	27,655	11,827	88,599
General and administration	377,202	305,955	1,305,110	1,027,875	13,111,347
TOTAL OPERATING EXPENSES	387,676	313,096	1,332,765	824,559	20,673,727
LOSS FROM OPERATIONS	(387,676)	(313,096)	(1,332,765)	(824,559)	(20,673,727)
Other expense- Interest	(56,919)	(37,534)	(144,240)	(126,711)	(372,018)
Other Income-Interest	0	0	0	0	272,594
LOSS BEFORE INCOME TAXES	(444,595)	(350,630)	(1,477,005)	(951,270)	(20,773,151)
Income taxes	0	0	0	0	0
NET LOSS	$ (444,595)	$ (350,630)	$ (1,477,005)	$ (951,270)	$ (20,773,151)
Loss per share - basic and diluted	$ (0.01)	$ (0.01)	$ (0.04)	$ (0.04)
Weighted average common shares outstanding	33,961,413	27,433,000	33,215,599	27,031,172

XML

PROPERTY AND EQUIPMENT

9 Months Ended

Aug. 31, 2013

PROPERTY AND EQUIPMENT [Text Block]

4.	PROPERTY AND EQUIPMENT
	Property and equipment are recorded at cost less accumulated depreciation. Depreciation is provided commencing in the month following acquisition using the following annual rate and method:

Computer equipment	30%	declining balance method
Furniture and Fixtures	30%	declining balance method
Leasehold Improvements		straight line over period of lease
Moulds	20%	Straight line over 5 years

	August 31, 2013				November 30, 2012
			Accumulated				Accumulated
	Cost		Amortization		Cost		Amortization
	$		$		$		$
Computer equipment	37,573		30,592		37,573		28,565
Furniture and fixtures	18,027		13,575		18,027		12,282
Leasehold Improvements	23,721		9,283		8,252		8,252
Moulds	171,890		35,149		142,140		11,845
	251,211		88,599		205,992		60,944
Net carrying amount		$	162,612			$	145,048
Amortization expense		$	27,655			$	20,585
			(9months	)			(12months	)

XML

CAPITAL STOCK (Narrative) (Details)	9 Months Ended
	Aug. 31, 2013 USD ($)	Aug. 31, 2013 CAD
Capital Stock 1	100,000,000	100,000,000
Capital Stock 2	$ 0.001
Capital Stock 3	5,000,000	5,000,000
Capital Stock 4	0.001
Capital Stock 5	0.001
Capital Stock 6	50,000,000	50,000,000
Capital Stock 7	100,000,000	100,000,000
Capital Stock 8	5,000,000	5,000,000
Capital Stock 9	45,575,907	45,575,907
Capital Stock 10	1,801,480	1,801,480
Capital Stock 11	500,000
Capital Stock 12	40,444
Capital Stock 13	540,444
Capital Stock 14	1,801,480	1,801,480
Capital Stock 15	$ 0.30
Capital Stock 16	3,794,280
Capital Stock 17		3,993,980
Capital Stock 18	9,984,950	9,984,950
Capital Stock 19	0.38
Capital Stock 20		0.40
Capital Stock 21	734,565
Capital Stock 22		80,000
Capital Stock 23		359,458
Capital Stock 24	898,645	898,645
Capital Stock 25		0.40
Capital Stock 26	0.38
Capital Stock 27	700,000
Capital Stock 28	97,716
Capital Stock 29	2,297,044	2,297,044
Capital Stock 30	1,484,169	1,484,169
Capital Stock 31	411,828
Capital Stock 32	33,423
Capital Stock 33	445,251
Capital Stock 34	1,484,169	1,484,169
Capital Stock 35	$ 0.30
Capital Stock 36	1,333,333	1,333,333
Capital Stock 37	$ 0.30
Capital Stock 38	400,000
Capital Stock 39	994,380	994,380
Capital Stock 40	146,500
Capital Stock 41	23,076
Capital Stock 42	169,576
Capital Stock 43	994,380	994,380
Capital Stock 44	832,501	832,501
Capital Stock 45	$ 0.30
Capital Stock 46	$ 249,750

XML

LOAN FROM RELATED PARTY

9 Months Ended

Aug. 31, 2013

LOAN FROM RELATED PARTY [Text Block]

12.

LOAN FROM RELATED PARTY

On March 14, 2013, the Company obtained an unsecured loan of $94,970 (CAD$100,000) for general working capital purposes (“Working Capital Loan”) from a director. The Working Capital Loan , together with interest at 6% per annum, accrued and calculated daily, plus $6,000 will be repaid on the earlier of July 30, 2013 and demand. The Company has accrued interest of $8,811 for the nine month period ended August 31, 2013. The Company also granted 50,000 warrants to the lender as bonus consideration for the loan. These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years.  This loan along with interest was repaid subsequent to the quarter (see subsequent event note 13(b))

XML

Schedule of Stockholders' Equity Note, Warrants or Rights Issued on January 4, 2012 (Details) (USD $)	9 Months Ended
	Aug. 31, 2013
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On January 4, 2012 1	2.00%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On January 4, 2012 2	0.00%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On January 4, 2012 3	0.00%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On January 4, 2012 4	206.87%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On January 4, 2012 5	0.13
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On January 4, 2012 6	$ 100,148

XML

RELATED PARTY TRANSACTIONS (Narrative) (Details)	9 Months Ended
	Aug. 31, 2013 USD ($)	Aug. 31, 2013 CAD
Related Party Transactions 1	$ 233,400
Related Party Transactions 2	5,400
Related Party Transactions 3	34,730
Related Party Transactions 4	180,000
Related Party Transactions 5	92,735
Related Party Transactions 6	100,000	100,000
Related Party Transactions 7	94,970
Related Party Transactions 8		100,000
Related Party Transactions 9	$ 0.50
Related Party Transactions 10	15,637
Related Party Transactions 11	8,811
Related Party Transactions 12	198,000
Related Party Transactions 13	4,800
Related Party Transactions 14	775,000	775,000
Related Party Transactions 15	20,000	20,000
Related Party Transactions 16	795,000	795,000
Related Party Transactions 17	$ 0.13
Related Party Transactions 18	99,522
Related Party Transactions 19	800,000	800,000
Related Party Transactions 20	$ 0.13
Related Party Transactions 21	100,148
Related Party Transactions 22	400,000	400,000
Related Party Transactions 23	$ 0.20
Related Party Transactions 24	75,013
Related Party Transactions 25	18,050
Related Party Transactions 26	$ 151,600

XML

STOCK PURCHASE WARRANTS (Narrative) (Details)	9 Months Ended
	Aug. 31, 2013 USD ($)	Aug. 31, 2013 CAD
Stock Purchase Warrants 1	800,000	800,000
Stock Purchase Warrants 2	$ 0.13
Stock Purchase Warrants 3	$ 100,148
Stock Purchase Warrants 4	850,000	850,000
Stock Purchase Warrants 5	0.25
Stock Purchase Warrants 6	850,000	850,000
Stock Purchase Warrants 7	0.25
Stock Purchase Warrants 8	400,000	400,000
Stock Purchase Warrants 9	$ 0.20
Stock Purchase Warrants 10	75,013
Stock Purchase Warrants 11	75,000	75,000
Stock Purchase Warrants 12	$ 0.42
Stock Purchase Warrants 13	28,911
Stock Purchase Warrants 14	905,000	905,000
Stock Purchase Warrants 15	905,000	905,000
Stock Purchase Warrants 16	905,000	905,000
Stock Purchase Warrants 17	905,000	905,000
Stock Purchase Warrants 18	100,000	100,000
Stock Purchase Warrants 19	193,400
Stock Purchase Warrants 20		200,000
Stock Purchase Warrants 21	$ 0.50
Stock Purchase Warrants 22	50,000	50,000
Stock Purchase Warrants 23	96,700
Stock Purchase Warrants 24		100,000
Stock Purchase Warrants 25	$ 0.50
Stock Purchase Warrants 26	100,000	100,000
Stock Purchase Warrants 27	193,400
Stock Purchase Warrants 28		200,000
Stock Purchase Warrants 29	$ 0.50
Stock Purchase Warrants 30	75,000	75,000
Stock Purchase Warrants 31	145,050
Stock Purchase Warrants 32		150,000
Stock Purchase Warrants 33	$ 0.50
Stock Purchase Warrants 34		3,794,280
Stock Purchase Warrants 35		3,993,980
Stock Purchase Warrants 36	9,984,950	9,984,950
Stock Purchase Warrants 37	0.38
Stock Purchase Warrants 38		0.40
Stock Purchase Warrants 39	898,645	898,645
Stock Purchase Warrants 40		0.40
Stock Purchase Warrants 41	$ 0.38

XML

Schedule of Property, Plant and Equipment (Details) (USD $)	9 Months Ended
	Aug. 31, 2013
Property And Equipment Schedule Of Property, Plant And Equipment 1	$ 37,573
Property And Equipment Schedule Of Property, Plant And Equipment 2	30,592
Property And Equipment Schedule Of Property, Plant And Equipment 3	37,573
Property And Equipment Schedule Of Property, Plant And Equipment 4	28,565
Property And Equipment Schedule Of Property, Plant And Equipment 5	18,027
Property And Equipment Schedule Of Property, Plant And Equipment 6	13,575
Property And Equipment Schedule Of Property, Plant And Equipment 7	18,027
Property And Equipment Schedule Of Property, Plant And Equipment 8	12,282
Property And Equipment Schedule Of Property, Plant And Equipment 9	23,721
Property And Equipment Schedule Of Property, Plant And Equipment 10	9,283
Property And Equipment Schedule Of Property, Plant And Equipment 11	8,252
Property And Equipment Schedule Of Property, Plant And Equipment 12	8,252
Property And Equipment Schedule Of Property, Plant And Equipment 13	171,890
Property And Equipment Schedule Of Property, Plant And Equipment 14	35,149
Property And Equipment Schedule Of Property, Plant And Equipment 15	142,140
Property And Equipment Schedule Of Property, Plant And Equipment 16	11,845
Property And Equipment Schedule Of Property, Plant And Equipment 17	251,211
Property And Equipment Schedule Of Property, Plant And Equipment 18	88,599
Property And Equipment Schedule Of Property, Plant And Equipment 19	205,992
Property And Equipment Schedule Of Property, Plant And Equipment 20	60,944
Property And Equipment Schedule Of Property, Plant And Equipment 21	162,612
Property And Equipment Schedule Of Property, Plant And Equipment 22	145,048
Property And Equipment Schedule Of Property, Plant And Equipment 23	27,655
Property And Equipment Schedule Of Property, Plant And Equipment 24	$ 20,585

XML

Schedule of Stockholders' Equity Note, Warrants or Rights Issued on October 3, 2012 (Details) (USD $)	9 Months Ended
	Aug. 31, 2013
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On October 3, 2012 1	1.50%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On October 3, 2012 2	0.00%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On October 3, 2012 3	0.00%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On October 3, 2012 4	199.60%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On October 3, 2012 5	0.42
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On October 3, 2012 6	$ 28,911

XML

LOAN FROM RELATED PARTY (Narrative) (Details)	9 Months Ended
	Aug. 31, 2013 USD ($)	Aug. 31, 2013 CAD
Loan From Related Party 1	$ 94,970
Loan From Related Party 2		100,000
Loan From Related Party 3	6.00%	6.00%
Loan From Related Party 4	6,000
Loan From Related Party 5	$ 8,811
Loan From Related Party 6	50,000	50,000
Loan From Related Party 7	$ 0.50

XML

Schedule of Stockholders' Equity Note, Warrants or Rights Issued on April 12, 2013 (Details) (USD $)	9 Months Ended
	Aug. 31, 2013
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On April 12, 2013 1	1.35%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On April 12, 2013 2	0.00%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On April 12, 2013 3	0.00%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On April 12, 2013 4	168.05%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On April 12, 2013 5	0.35
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On April 12, 2013 6	$ 25,351

XML

STOCK BASED COMPENSATION (Narrative) (Details) (USD $)	9 Months Ended
	Aug. 31, 2013
Stock Based Compensation 1	1,000,000
Stock Based Compensation 2	2,250,000
Stock Based Compensation 3	4,500,000
Stock Based Compensation 4	5,000,000
Stock Based Compensation 6	150,000
Stock Based Compensation 7	20.00%
Stock Based Compensation 8	4,319,000
Stock Based Compensation 9	775,000
Stock Based Compensation 10	20,000
Stock Based Compensation 11	110,000
Stock Based Compensation 12	905,000
Stock Based Compensation 13	$ 0.13
Stock Based Compensation 14	905,000
Stock Based Compensation 15	905,000
Stock Based Compensation 16	905,000
Stock Based Compensation 17	905,000
Stock Based Compensation 18	850,000
Stock Based Compensation 19	$ 0.25
Stock Based Compensation 20	850,000
Stock Based Compensation 21	0.25
Stock Based Compensation 22	100,000
Stock Based Compensation 23	200,000
Stock Based Compensation 24	200,000
Stock Based Compensation 25	$ 0.42
Stock Based Compensation 26	1,000,000
Stock Based Compensation 27	100,000
Stock Based Compensation 28	1,100,000
Stock Based Compensation 29	1,100,000
Stock Based Compensation 30	$ 0.45
Stock Based Compensation 31	0
Stock Based Compensation 32	$ 0

XML

Interim Statement of Changes in Stockholders' Equity (USD $)	Common Shares [Member]	Additional Paid-In Capital [Member]	Deficit Accumulated During Development Stage [Member]	Total
Beginning Balance at Mar. 01, 2005
Issuance of Common shares for professional services	$ 6,525	$ 58,725		$ 65,250
Issuance of Common shares for professional services (Shares)	6,525,000
Issuance of common shares for cash	398	99,072		99,470
Issuance of common shares for cash (Shares)	397,880
Net loss for the year			(188,699)	(188,699)
Ending Balance at Nov. 30, 2005	6,923	157,797	(188,699)	(23,979)
Ending Balance (Shares) at Nov. 30, 2005	6,922,880
Issuance of common shares for cash	956	94,644		95,600
Issuance of common shares for cash (Shares)	956,000
Issuance of Common Shares for cash 2	286	49,764		50,050
Issuance of Common Shares for cash 2 (Shares)	286,000
Issuance of common shares to consultant for services	50	8,700		8,750
Issuance of common shares to consultant for services (Shares)	50,000
Issuance of Common Shares for Cash 3	2,000	398,000		400,000
Issuance of Common Shares for Cash 3 (Shares)	2,000,000
Exercise of stock options	950	94,050		95,000
Exercise of stock options (Shares)	950,000
Issuance of common shares for cash (net of agent commission)	200	179,785		179,985
Issuance of common shares for cash (net of agent commission) (Shares)	200,000
Stock subscriptions received		1,165,500		1,165,500
Stock based compensation		1,049,940		1,049,940
Net loss for the year			(1,660,799)	(1,660,799)
Ending Balance at Nov. 30, 2006	11,365	3,198,180	(1,849,498)	1,360,047
Ending Balance (Shares) at Nov. 30, 2006	11,364,880
Issuance of common shares for cash	1,171	1,169,499		1,170,670
Issuance of common shares for cash (Shares)	1,170,670
Issuance of common shares for cash and services	50	154,950		155,000
Issuance of common shares for cash and services (Shares)	50,000
Issuance of common shares for cash (net of expenses)	2,139	4,531,236		4,533,375
Issuance of common shares for cash (net of expenses) (Shares)	2,139,000
Cancellation of stock	(1,560)	(14,040)		(15,600)
Cancellation of stock (Shares)	(1,560,000)
Issue of warrants		357,094		357,094
Issuance of common shares for Common shares issued for stock subscriptions received in prior year	1,165	(1,165)
Issuance of common shares for Common shares issued for stock subscriptions received in prior year (Shares)	1,165,500
Stock based compensation		2,446,433		2,446,433
Net loss for the year			(4,827,937)	(4,827,937)
Ending Balance at Nov. 30, 2007	14,330	11,842,187	(6,677,435)	5,179,082
Ending Balance (Shares) at Nov. 30, 2007	14,330,050
Exercise of stock options	117	11,583		11,700
Exercise of stock options (Shares)	117,000
Stock based compensation		1,231,056		1,231,056
Net loss for the year			(4,401,786)	(4,401,786)
Ending Balance at Nov. 30, 2008	14,447	13,084,826	(11,079,221)	2,020,052
Ending Balance (Shares) at Nov. 30, 2008	14,447,050
Issuance of common shares for cash	788	196,212		197,000
Issuance of common shares for cash (Shares)	788,000
Compensation expense for warrants		4,223		4,223
Stock based compensation		177,990		177,990
Net loss for the year			(2,974,467)	(2,974,467)
Ending Balance at Nov. 30, 2009	15,235	13,463,251	(14,053,688)	(575,202)
Ending Balance (Shares) at Nov. 30, 2009	15,235,050
Issuance of common shares for cash	8,143	1,665,157		1,673,300
Issuance of common shares for cash (Shares)	8,143,000
Stock subscriptions received		30,000		30,000
Issuance of common shares For services	2,500	428,000		430,500
Issuance of common shares For services (Shares)	2,500,000
Stock based compensation		289,670		289,670
Net loss for the year			(2,320,962)	(2,320,962)
Ending Balance at Nov. 30, 2010	25,878	15,876,078	(16,374,650)	(472,694)
Ending Balance (Shares) at Nov. 30, 2010	25,878,050
Issuance of common shares for cash	800	159,200		160,000
Issuance of common shares for cash (Shares)	800,000
Issuance of common shares for Common shares issued for stock subscriptions received in prior year	150	(150)
Issuance of common shares for Common shares issued for stock subscriptions received in prior year (Shares)	150,000
Beneficial conversion features on convertible debt		29,300		29,300
Net loss for the year			(901,558)	(901,558)
Ending Balance at Nov. 30, 2011	26,828	16,064,428	(17,276,208)	(1,184,952)
Ending Balance (Shares) at Nov. 30, 2011	26,828,050
Issuance of common shares for cash	2,165	647,585		649,750
Issuance of common shares for cash (Shares)	2,165,834
Beneficial conversion features on convertible debt		50,000		50,000
Conversion of convertible debt to common shares	2,479	647,508		649,987
Conversion of convertible debt to common shares (Shares)	2,478,549
Stock based compensation		929,365		929,365
Net loss for the year			(2,019,938)	(2,019,938)
Ending Balance at Nov. 30, 2012	31,472	18,338,886	(19,296,146)	(925,788)
Ending Balance (Shares) at Nov. 30, 2012	31,472,433
Issuance of common shares for cash	9,985	3,059,715		3,069,700
Issuance of common shares for cash (Shares)	9,984,950
Conversion of convertible debt to common shares	1,802	538,642		540,444
Conversion of convertible debt to common shares (Shares)	1,801,480
Conversion of convertible debt to common shares2	2,297	795,419		797,716
Conversion of convertible debt to common shares2 (Shares)	2,297,044
Common share reconciliation difference with transfer agent	20	(20)
Common share reconciliation difference with transfer agent (Shares)	20,000
Stock based compensation		99,245		99,245
Net loss for the year			(1,477,005)	(1,477,005)
Ending Balance at Aug. 31, 2013	$ 45,576	$ 22,831,887	$ (20,773,151)	$ 2,104,312
Ending Balance (Shares) at Aug. 31, 2013	45,575,907

XML

NATURE OF OPERATIONS AND GOING CONCERN

9 Months Ended

Aug. 31, 2013

NATURE OF OPERATIONS AND GOING CONCERN [Text Block]

2.	NATURE OF OPERATIONS
	The Company is a non-lethal defense technology company, specializing in the development of innovative next generation solutions for security situations that do not require the use of lethal force. SDI has implemented manufacturing partnerships to assist in the deployment of their patented and patent pending family of products. These products consist of: the Blunt Impact Projectile 40mm (BIP) line of products and the Wireless Electric Projectile 40mm (WEP).
	These unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year.
	The Company is in the development stage and has not yet realized revenues from its planned operations. The Company has incurred a cumulative loss of $20,773,151 from inception to August 31, 2013 which includes a non-cash stock based compensation expense of $6,585,016 for issue of options and warrants. The Company has funded operations through the issuance of capital stock and convertible debentures.

In addition to raising funds in the prior years, the Company raised $160,000 through the issuance of 800,000 common shares during the year ended November 30, 2011. The Company further raised an additional $878,328 by issue of Convertible Debentures during the year ended November 30, 2011 and $910,000 during the year ended November 30, 2012. In addition, the Company raised $649,750 by issuance of 2,165,834 common shares during the year ended November 30, 2012. On August 15, 2013, the Company filed an amended and restated final prospectus (the “Prospectus”) in Canada, in the provinces of Alberta, British Columbia and Ontario for listing its shares in these provinces in Canada. On August 27, 2013 the Company completed an initial public offering to raise gross proceeds of CDN $3,993,980 (US $3,794,280) through the issuance of 9,984,950 Common Shares at a price of CDN$0.40 (US $0.38) per Common Share (the “Issue Price”). The Company’s common shares commenced trading on the TSX Venture Exchange (“TSX”) under the symbol “SDZ”.

While the Company has been successful in securing financings in the past, there is no assurance that it will be able to do so in the future. Accordingly, these financial statements do not give effect to adjustments, if any, that would be necessary should the Company be unable to continue as a going concern.

XML

CAPITAL STOCK

9 Months Ended

Aug. 31, 2013

CAPITAL STOCK [Text Block]

5. CAPITAL STOCK

a)	Authorized
	100,000,000 * Common shares, $0.001 par value And        5,000,000 Preferred shares, $0.001 par value

*On March 20, 2013 the Company filed with the Secretary of the State of Delaware a certificate of amendment (the “Amendment”) to the Company’s certificate of incorporation. The Amendment increased the number of authorized shares of the Company’s common stock, par value $0.001, from 50,000,000 to 100,000,000 common shares.

The Company’s Articles of Incorporation authorize its Board of Directors to issue up to 5,000,000 shares of preferred stock. The provisions in the Articles of Incorporation relating to the preferred stock allow the directors to issue preferred stock with multiple votes per share and dividend rights, which would have priority over any dividends paid with respect to the holders of SDI’s common stock.

b)	Issued
	45,575,907 Common shares

c)	Changes to Issued Share Capital
	Nine- months ended August 31, 2013
	During the six month period ended May 31, 2013 the Company issued 1,801,480 common shares for conversion of convertible debentures having face value of $500,000 and accrued interest of $40,444. The total debt for $540,444 was converted into 1,801,480 common shares at $0.30 per share.
	On August 15, 2013, the Company filed an amended and restated final prospectus (the “Prospectus”) in Canada, in the provinces of Alberta, British Columbia and Ontario to list its common shares (“Common Shares”) on the TSXV.
	On August 27, 2013, the Company completed an initial public offering to raise gross proceeds of $3,794,280 (CAD $3,993,980) through the issuance of 9,984,950 Common Shares at a price of $0.38 (CAD$0.40) per Common Share (the “Issue Price”). The company incurred expenses of $734,565 to raise the capital which included a fee of CAD $80,000 paid to a former director and CEO in accordance with the terms of an agreement regarding escrow of shares and a cash commission of CAD$359,458 paid to the Agent. In addition the Company granted an option (the “Agent’s Option”) to purchase up to 898,645 Common Shares to the Agent and members of its selling group. The Agent’s Option entitles the Agent and members of its selling group to purchase Common Shares at a price of CAD$0.40 (US $0.38) per Common Share until August 27, 2015.
	Upon completion of the Offering, $700,000 face value of convertible debentures along with $97,716 of interest was converted to 2,297,044 Common Shares, resulting in the discharge of those debentures.
	Year ended November 30, 2012
	During the three month period ended August 31, 2012, the Company issued 1,484,169 common shares for conversion of convertible debentures having face value of $411,828 (Convertible debenture 2) and accrued interest of $33,423. The total debt for $445,251 was converted into 1,484,169 common shares at $0.30 per share.
	During the three month period ended August 31, 2012, the Company issued 1,333,333 shares of common stock to private investors at a price of $0.30 per share for a total consideration of $400,000. The shares of common stock are restricted securities, as that term is defined in Rule 144 of the Securities and Exchange Commission. The Company relied upon the exemption provided by Section 4(2) of the Securities Act of 1933 in connection with the sale of these securities.
	During the three month period ended November 30, 2012, the Company issued 994,380 common shares for conversion of convertible debentures having a face value of $146,500 (Convertible debenture 1) and accrued interest of $23,076. The total debt for $169,576 was converted into 994,380 common shares.
	During the three month period ended November 30, 2012, the Company issued 832,501 shares of common stock to private investors at a price of $0.30 per share for a total consideration of $249,750. The shares of common stock are restricted securities, as that term is defined in Rule 144 of the Securities and Exchange Commission. The Company relied upon the exemption provided by Section 4(2) of the Securities Act of 1933 in connection with the sale of these securities.

XML

RESEARCH AND PRODUCT DEVELOPMENT

9 Months Ended

Aug. 31, 2013

RESEARCH AND PRODUCT DEVELOPMENT [Text Block]

3.	RESEARCH AND PRODUCT DEVELOPMENT
	Research and Product Development costs, including acquired research and product development costs, are charged against income in the period incurred.

XML

Schedule of Stockholders' Equity Note, Warrants or Rights Issued on January 30, 2013 (Details) (USD $)	9 Months Ended
	Aug. 31, 2013
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On January 30, 2013 1	1.35%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On January 30, 2013 2	0.00%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On January 30, 2013 3	0.00%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On January 30, 2013 4	187.87%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On January 30, 2013 5	0.47
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On January 30, 2013 6	$ 38,183

XML

COMMITMENTS (Narrative) (Details) (USD $)	9 Months Ended
	Aug. 31, 2013 D
Commitments 1	8,500
Commitments 2	5.00%
Commitments 3	30
Commitments 4	12,000
Commitments 5	5.00%
Commitments 6	600
Commitments 7	$ 480,000
Commitments 8	180,000
Commitments 9	$ 0.45
Commitments 10	7,000
Commitments 11	30
Commitments 12	7,000
Commitments 13	30
Commitments 14	6,399
Commitments 15	1,418

XML

SUBSEQUENT EVENTS (Narrative) (Details)	9 Months Ended
	Aug. 31, 2013 USD ($)	Aug. 31, 2013 CAD
Subsequent Events 1		382,014
Subsequent Events 2		0.30
Subsequent Events 3	1,273,378	1,273,378
Subsequent Events 4	94,970
Subsequent Events 5		100,000
Subsequent Events 6	189,940
Subsequent Events 7		200,000

XML

Schedule of Share-based Compensation and Assumptions as of October 26, 2012 (Details) (USD $)	9 Months Ended
	Aug. 31, 2013
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 26, 2012 1	1.65%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 26, 2012 2	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 26, 2012 3	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 26, 2012 4	217.15%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 26, 2012 5	0.50
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 26, 2012 6	$ 534,905

XML

Interim Balance Sheets (Parenthetical) (USD $)	Aug. 31, 2013	Nov. 30, 2012
Preferred Stock, Par Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	45,575,907	31,472,433
Common Stock, Shares, Outstanding	45,575,907	31,472,433

XML

RELATED PARTY TRANSACTIONS

9 Months Ended

Aug. 31, 2013

RELATED PARTY TRANSACTIONS [Text Block]

8.	RELATED PARTY TRANSACTIONS
	The following transactions are in the normal course of operations and are measured at the exchange amount, which is the amount of consideration established and agreed to by the related parties.
	Nine months ended August 31, 2013
	The directors were compensated as per their consulting agreements with the Company. The Company expensed a total of $233,400 as management fees to its three directors and expensed a total of $5,400 as automobile allowance.
	The Company expensed $34,730 for services provided by the CFO of the Company and $180,000 for services provided by a corporation in which the Chief Operating Officer has an interest.
	The Company reimbursed $92,735 to directors and officers for travel and entertainment expenses incurred for the Company.
	On March 4, the board of directors granted 100,000 warrants as an incentive to a director who provided a working capital loan of $94,970 (CAD $100,000). These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. The Company expensed $15,637 as compensation expense. In addition the Company has accrued interest of $8,811 till August 31, 2013.
	Nine months ended August 31, 2012
	The directors were compensated as per their consulting agreements with the Company. The Company expensed a total of $198,000 as Management fees for payment to its three directors and expensed a total of $4,800 as automobile allowance.

On January 4, 2012, the board of directors granted options to three directors to acquire a total of 775,000 common shares and one officer to acquire 20,000 common shares. All these 795,000 options were issued at an exercise price of $0.13 per share and vest immediately with an expiry term of four years. The Company expensed stock based compensation cost of $99,522 for these options.

On January 4, 2012, the board of directors issued warrants to a Company in which the Chief Operating officer has an interest in, to acquire a total of 800,000 common shares. These warrants were issued at an exercise price of $0.13 per share with an expiry term of four years. The Company expensed stock based compensation cost of $100,148.

On August 9, 2012, the board of directors issued warrants to a Company owned and controlled by a director, to acquire a total of 400,000 common shares. These warrants were issued at an exercise price of $0.20 per share with an expiry term of four years. The Company expensed stock based compensation cost of $75,013.

The Company expensed $18,050 for services provided by the CFO of the Company and $151,600 for services provided by a Company in which the Chief Operating Officer has an interest.

XML

Interim Statements of Cash Flows (USD $)	9 Months Ended		102 Months Ended
	Aug. 31, 2013	Aug. 31, 2012	Aug. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss for the period	$ (1,477,005)	$ (951,270)	$ (20,773,151)
Items not requiring an outlay of cash:
Issue of shares for services	0	0	584,500
Fair value of options and warrants (included in general and administration expenses)	99,245	288,453	6,585,016
Recovery of accounts payable	0	(215,143)	(215,143)
Loss on cancellation of common stock	0	0	34,400
Amortization of plant and equipment	27,655	11,827	88,599
Amortization of debt discount	37,361	19,256	79,300
Amortization of deferred financing cost	0	10,916	35,160
Changes in non-cash working capital:
Prepaid expenses and other receivables	(6,829)	98,392	(14,029)
Deferred costs	32,500	0	0
Accounts payable and accrued liabilities*	331,033	(144,217)	753,043
NET CASH USED IN OPERATING ACTIVITIES	(956,040)	(881,786)	(12,842,305)
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of Plant and Equipment	(45,219)	(147,219)	(251,211)
NET CASH USED IN INVESTING ACTIVITIES	(45,219)	(147,219)	(251,211)
CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from issuance of common shares	3,069,700	400,000	13,538,600
Proceeds (repayment) from convertible debentures	(30,000)	910,000	1,758,328
Cancellation of common stock	0	0	(50,000)
Loan from related party	94,970	0	94,970
Loan from non-related parties	522,335	0	522,335
Exercise of stock options	0	0	117,500
NET CASH PROVIDED BY FINANCING ACTIVITIES	3,657,005	1,310,000	15,981,733
NET INCREASE IN CASH FOR THE PERIOD	2,655,746	280,995	2,888,217
Cash, beginning of period	232,471	114,835	0
CASH, END OF PERIOD	2,888,217	395,830	2,888,217
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS:
INCOME TAXES PAID	0	0	0
INTEREST PAID	$ 6,901	$ 0	$ 0

XML

Interim Balance Sheets (USD $)	Aug. 31, 2013	Nov. 30, 2012
CURRENT
Cash	$ 2,888,217	$ 232,471
Deferred costs	0	32,500
Prepaid expenses and other receivables	14,029	7,200
Total Current Assets	2,902,246	272,171
Property and Equipment	162,612	145,048
TOTAL ASSETS	3,064,858	417,219
CURRENT LIABILITIES
Accounts payable and accrued liabilities	343,241	150,368
Loan from related party	94,970	0
Loans from non-related parties	522,335	0
Total Current Liabilities	960,546	150,368
Convertible Debentures	0	1,192,639
Total Liabilities	960,546	1,343,007
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil issued and outstanding (2012 - nil)	0	0
Common stock, $0.001 par value, 100,000,000 shares authorized, 45,575,907 issued and outstanding (2012 -31,472,433)	45,576	31,472
Additional Paid-In Capital	22,831,887	18,338,886
Deficit Accumulated During the Development Stage	(20,773,151)	(19,296,146)
Total Stockholders' Equity (Deficit)	2,104,312	(925,788)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 3,064,858	$ 417,219

XML

CONVERTIBLE DEBENTURES (Narrative) (Details) (USD $)	9 Months Ended
	Aug. 31, 2013
Convertible Debentures 1	1,801,480
Convertible Debentures 2	$ 500,000
Convertible Debentures 3	40,444
Convertible Debentures 4	540,444
Convertible Debentures 5	1,801,480
Convertible Debentures 6	$ 0.30
Convertible Debentures 7	700,000
Convertible Debentures 8	97,716
Convertible Debentures 9	2,297,044
Convertible Debentures 10	30,000
Convertible Debentures 11	3,877
Convertible Debentures 12	$ 3,024

XML

NATURE OF OPERATIONS AND GOING CONCERN (Narrative) (Details)	9 Months Ended
	Aug. 31, 2013 USD ($)	Aug. 31, 2013 CAD
Nature Of Operations And Going Concern 1	$ 20,773,151
Nature Of Operations And Going Concern 2	6,585,016
Nature Of Operations And Going Concern 3	160,000
Nature Of Operations And Going Concern 4	800,000	800,000
Nature Of Operations And Going Concern 5	878,328
Nature Of Operations And Going Concern 6	910,000
Nature Of Operations And Going Concern 7	649,750
Nature Of Operations And Going Concern 8	2,165,834	2,165,834
Nature Of Operations And Going Concern 9		3,993,980
Nature Of Operations And Going Concern 10	3,794,280
Nature Of Operations And Going Concern 11	9,984,950	9,984,950
Nature Of Operations And Going Concern 12		0.40
Nature Of Operations And Going Concern 13	$ 0.38

XML

Schedule of Stockholders' Equity Note, Warrants or Rights Issued on May 14, 2013 (Details) (USD $)	9 Months Ended
	Aug. 31, 2013
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On May 14, 2013 1	1.35%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On May 14, 2013 2	0.00%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On May 14, 2013 3	0.00%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On May 14, 2013 4	181.17%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On May 14, 2013 5	0.35
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On May 14, 2013 6	$ 20,074

XML

Schedule of Stockholders' Equity Note, Warrants or Rights Issued on August 09, 2012 (Details) (USD $)	9 Months Ended
	Aug. 31, 2013
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On August 09, 2012 1	3.63%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On August 09, 2012 2	0.00%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On August 09, 2012 3	0.00%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On August 09, 2012 4	183.31%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On August 09, 2012 5	0.20
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On August 09, 2012 6	$ 75,013

XML

Schedule of Share-based Compensation and Assumptions as of January 4, 2012 (Details) (USD $)	9 Months Ended
	Aug. 31, 2013
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of January 4, 2012 1	2.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of January 4, 2012 2	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of January 4, 2012 3	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of January 4, 2012 4	206.87%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of January 4, 2012 5	0.13
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of January 4, 2012 6	$ 113,292

XML

Schedule of Share-based Compensation and Assumptions as of October 3, 2012 (Details) (USD $)	9 Months Ended
	Aug. 31, 2013
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 3, 2012 1	1.50%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 3, 2012 2	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 3, 2012 3	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 3, 2012 4	199.60%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 3, 2012 5	0.42
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 3, 2012 6	$ 77,096

XML

STOCK PURCHASE WARRANTS

9 Months Ended

Aug. 31, 2013

STOCK PURCHASE WARRANTS [Text Block]

7.	STOCK PURCHASE WARRANTS
	Year ended November 30, 2012
	On January 4, 2012, the board of directors issued warrants to a Company in which the Chief Operating officer has an interest in, to acquire a total of 800,000 common shares. These warrants were issued at an exercise price of $0.13 per share with an expiry term of four years. The Company expensed stock based compensation cost of $100,148. The fair value of each warrant used for the purpose of estimating the compensation expense is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		2.00%
Expected dividends		0%
Forfeiture rate		0%
Volatility		206.87%
Market price of Company’s common stock on date of grant of options	$	0.13
Compensation expense	$	100,148

On March 9, 2012, all of the issued and outstanding stock options for common shares in the Company’s capital stock previously issued to Elad, Ilan Shalev and Haim Danon (being principals of Elad) were exchanged into warrants on terms identical to the terms of the existing stock options in the Company. The Company thus cancelled 850,000 options having an exercise price of $0.25 per common share and expiring on June 30, 2014 and issued 850,000 warrants at exercise price of $0.25 per common share and expiring June 30, 2014 (see note 6)

On August 9, 2012, the board of directors issued warrants to a Company owned and controlled by a director, to acquire a total of 400,000 common shares. These warrants were issued at an exercise price of $0.20 per share with an expiry term of four years. The Company expensed stock based compensation cost of $75,013. The fair value of each warrant used for the purpose of estimating the compensation expense is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		3.63%
Expected dividends		0%
Forfeiture rate		0%
Volatility		183.31%
Market price of Company’s common stock on date of grant of options	$	0.20
Compensation expense	$	75,013

On October 3, 2012, the board of directors issued warrants to a consultant, to acquire a total of 75,000 common shares. These warrants were issued at an exercise price of $0.42 per share with an expiry term of three years. The Company expensed stock based compensation cost of $28,911. The fair value of each warrant used for the purpose of estimating the compensation expense is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		1.5%
Expected dividends		0%
Forfeiture rate		0%
Volatility		199.60%
Market price of Company’s common stock on date of grant of options	$	0.42
Compensation expense	$	28,911

On September 19, 2012 the board of directors approved the cancellation of 905,000 options issued on January 4, 2012, to be exchanged into 905,000 warrants on terms identical to the terms of the existing stock options in the Company. The cancellation of 905,000 options and issuance of 905,000 warrants in lieu thereof was effective October 8, 2012 (see note 6).

Nine months ended August 31, 2013

On January 30, 2013, the board of directors granted 100,000 warrants as an incentive to a lender who provided a working capital loan of $193,400 (CAD $200,000). These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. The fair value of incentive warrants used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		1.35%
Expected dividends		0%
Forfeiture rate		0%
Volatility		187.87%
Market price of Company’s common stock on date
of grant of options	$	0.47
Compensation expense	$	38,183

On March 14, the board of directors granted 50,000 warrants as an incentive to a director who provided a working capital loan of $96,700 (CAD $100,000). These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. The fair value of incentive warrants used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		1.35%
Expected dividends		0%
Forfeiture rate		0%
Volatility		182.13%
Market price of Company’s common stock on date of grant of options	$	0.40
Compensation expense	$	15,637

On April 12, 2013, the board of directors granted 100,000 warrants as an incentive to a lender who provided a working capital loan of $193,400 (CAD $200,000).. These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. The fair value of incentive warrants used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		1.35%
Expected dividends		0%
Forfeiture rate		0%
Volatility		168.05%
Market price of Company’s common stock on date of grant of options	$	0.35
Compensation expense	$	25,351

On May 14, 2013, the board of directors granted 75,000 warrants as an incentive to a lender who provided a working capital loan of $145,050 (CAD$150,000). These warrants were issued at an exercise price of $0.50 per share and vest immediately with an expiry term of two years. The fair value of incentive warrants used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		1.35%
Expected dividends		0%
Forfeiture rate		0%
Volatility		181.17%
Market price of Company’s common stock on date of grant of options	$	0.35
Compensation expense	$	20,074

On August 27, 2013, the Company completed an initial public offering to raise gross proceeds of CDN $3,794,280 (CAD $3,993,980) through the issuance of 9,984,950 Common Shares at a price of $0.38 (CDN$0.40) per Common Share (the “Issue Price”). The Company granted an option (the “Agent’s Option”) to purchase up to 898,645 Common Shares to the Agent and members of its selling group. The Agent’s Option entitles the Agent and members of its selling group to purchase Common Shares at a price of CDN$0.40 (US $0.38) per Common Share until August 27, 2015.

XML

LOANS FROM NON- RELATED PARTIES (Narrative) (Details)	9 Months Ended
	Aug. 31, 2013 USD ($)	Aug. 31, 2013 CAD
Loans From Non- Related Parties 1	$ 189,940
Loans From Non- Related Parties 2		200,000
Loans From Non- Related Parties 3	6.00%	6.00%
Loans From Non- Related Parties 4	12,000
Loans From Non- Related Parties 5	18,805
Loans From Non- Related Parties 6	100,000	100,000
Loans From Non- Related Parties 7	$ 0.50
Loans From Non- Related Parties 8	189,940
Loans From Non- Related Parties 9		200,000
Loans From Non- Related Parties 10	6.00%	6.00%
Loans From Non- Related Parties 11	12,000
Loans From Non- Related Parties 12	16,669
Loans From Non- Related Parties 13	100,000	100,000
Loans From Non- Related Parties 14	$ 0.50
Loans From Non- Related Parties 15	142,455
Loans From Non- Related Parties 16		150,000
Loans From Non- Related Parties 17	6.00%	6.00%
Loans From Non- Related Parties 18	9,000
Loans From Non- Related Parties 19	$ 11,712
Loans From Non- Related Parties 20	75,000	75,000
Loans From Non- Related Parties 21	$ 0.50

XML

Schedule of Stockholders' Equity Note, Warrants or Rights Issued on March 14, 2013 (Details) (USD $)	9 Months Ended
	Aug. 31, 2013
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On March 14, 2013 1	1.35%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On March 14, 2013 2	0.00%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On March 14, 2013 3	0.00%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On March 14, 2013 4	182.13%
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On March 14, 2013 5	0.40
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights Issued On March 14, 2013 6	$ 15,637

XML

CONVERTIBLE DEBENTURES

9 Months Ended

Aug. 31, 2013

CONVERTIBLE DEBENTURES [Text Block]

10.	CONVERTIBLE DEBENTURES
	During the six month period ended May 31, 2013 the Company issued 1,801,480 common shares for conversion of convertible debentures having face value of $500,000 and accrued interest of $40,444. The total debt for $540,444 was converted into 1,801,480 common shares at $0.30 per share.
	On August 27, 2013, upon completion of the Offering, $700,000 face value of convertible debentures along with $97,716 of interest was converted to 2,297,044 Common Shares, resulting in the discharge of those debentures. In addition, the Company repaid the balance of $30,000 face value of convertible debenture not converted along with accrued interest of $3,877 and also repaid interest of $3,024 not converted to common shares.

XML

STOCK BASED COMPENSATION

9 Months Ended

Aug. 31, 2013

STOCK BASED COMPENSATION [Text Block]

6.	STOCK BASED COMPENSATION
	Effective October 30, 2006 the Company adopted the following stock option and stock bonus plans which were replaced by the incentive stock option plan (the “2013 Plan”)
	Incentive Stock Option Plan . The Company’s Incentive Stock Option Plan authorizes the issuance of shares of its Common Stock to persons that exercise options granted pursuant to the Plan. Only employees may be granted options pursuant to the Incentive Stock Option Plan. The option exercise price is determined by its directors but cannot be less than the market price of its common stock on the date the option is granted. The Company has reserved 1,000,000 common shares under this plan. No options have been issued under this plan as at August 31, 2013.
	Non-Qualified Stock Option Plan . SDI’s Non-Qualified Stock Option Plan authorizes the issuance of shares of its Common Stock to persons that exercise options granted pursuant to the Plans. SDI’s employees, directors, officers, consultants and advisors are eligible to be granted options pursuant to the Plans, provided however that bona fide services must be rendered by such consultants or advisors and such services must not be in connection with the offer or sale of securities in a capital-raising transaction. By a resolution of the Board of Directors, the Company amended this plan to increase the number of common shares available under this plan from 2,250,000 to 4,500,000 effective October 10, 2007. The Company further amended its Non-Qualified Stock Option Plan to increase the number of Common Shares available under this plan to 5,000,000 and filed an S- 8 registration statement on April 10, 2008.

Stock Bonus Plan . SDI’s Stock Bonus Plan allows for the issuance of shares of common stock to its employees, directors, officers, consultants and advisors. However bona fide services must be rendered by the consultants or advisors and such services must not be in connection with the offer or sale of securities in a capital-raising transaction. The Company has reserved 150,000 common shares under this plan. No options have been issued under this plan as at August 31, 2013.

Effective May 31, 2013, the Company adopted an incentive stock option plan (the “2013 Plan”), which replaces the stock option and stock bonus plans that were in place prior to adoption of the 2013 Plan. All outstanding options to purchase Common Shares granted by the Company under the prior plans are now governed by the 2013 Plan and the prior plans (an Incentive Stock Option Plan, a Non-Qualified Stock Option Plan, and a Stock Bonus Plan) have been terminated.

The 2013 Plan authorizes the issuance that number of Common Shares as is equal to 20% of the issued and outstanding Common Shares. As a condition precedent to the TSXV issuing its final acceptance of listing of the Common Shares on the TSXV, all of the warrants previously issued by the Corporation in satisfaction of remuneration for services (in aggregate, warrants entitling the purchase of 4,319,000 Common Shares that were outstanding as of the date of filing of the amended and restated prospectus on August 15, 2013) are considered for purposes of the 2013 Plan reserve to be incentive stock options and included under the 2013 Plan reserve.

The Board of Directors administers the 2013 Plan. The Corporation’s employees, directors, officers, consultants and advisors are eligible to be granted options pursuant to 2013 Plan and in accordance with the policies of the TSXV, provided however that bona fide services must be rendered by such consultants or advisors and such services must not be in connection with the offer or sale of securities in a capital-raising transaction. In no instance shall an option be less than the market price of the Common Shares; the period during which options may be exercised cannot exceed ten years from the date of grant. No option shall be transferable or assignable. If there is any reclassification, consolidation or merger, the number of Common Shares subject to option and the option price per Common Share shall be proportionately adjusted in accordance with the terms of the 2013 Plan. The Board may attach other terms to the options at the time of grant. The Plan shall be governed by the laws of the Province of Ontario.

Year ended November 30, 2012

On January 4, 2012, the board of directors granted options to three directors to acquire a total of 775,000 common shares, one officer to acquire 20,000 common shares and two consultants to acquire a total of 110,000 common shares. The 905,000 options were issued at an exercise price of $0.13 per share and vest immediately with an expiry term of four years. The fair value of each option used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		2.00%
Expected dividends		0%
Forfeiture rate		0%
Volatility		206.87%
Market price of Company’s common stock on date of grant of options	$	0.13
Stock-based compensation cost	$	113,292

On September 19, 2012 the board of directors approved the cancellation of all the 905,000 options issued on January 4, 2012, as detailed above and to be exchanged into 905,000 warrants on terms identical to the terms of the existing stock options in the Company. The cancellation of 905,000 options and issuance of 905,000 warrants in lieu thereof was effective October 8, 2012.

On March 9, 2012, all of the issued and outstanding stock options for common shares in the Company’s capital stock previously issued to Elad, Ilan Shalev and Haim Danon (being principals of Elad) were exchanged into warrants on terms identical to the terms of the existing stock options in the Company. The Company thus cancelled 850,000 options having an exercise price of $0.25 per common share and expiring on June 30, 2014 and issued 850,000 warrants at exercise price of $0.25 per common share and expiring June 30, 2014.

On October 3, 2012, the board of directors granted options to two consultants to acquire 100,000 common shares each for a total of 200,000 common shares. The 200,000 options were issued at an exercise price of $0.42 per share and vest immediately with an expiry term of three years. The fair value of each option used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		1.50%
Expected dividends		0%
Forfeiture rate		0%
Volatility		199.60%
Market price of Company’s common stock on date of grant of options	$	0.42
Stock-based compensation cost	$	77,096

On October 26, 2012, the board of directors granted options to one director to acquire a total of 1,000,000 common shares and to another director to acquire 100,000 common shares for a total of 1,100,000 options. These 1,100,000 options were issued at an exercise price of $0.45 per share and vest immediately with an expiry term of four years. The fair value of each option used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions:

Risk free rate		1.65%
Expected dividends		0%
Forfeiture rate		0%
Volatility		217.15%
Market price of Company’s common stock on date of grant of options	$	0.50
Stock-based compensation cost	$	534,905

As of November 30, 2012 there was $Nil of unrecognized expense related to non-vested stock-based compensation arrangements granted.

Nine months ended August 31, 2013

The Company did not issue any options during the nine month period ended August 31, 2013

As of August 31, 2013 there was $Nil of unrecognized expense related to non-vested stock-based compensation arrangements granted.

XML

BASIS OF PRESENTATION

9 Months Ended

Aug. 31, 2013

BASIS OF PRESENTATION [Text Block]

1.	BASIS OF PRESENTATION
	The unaudited interim financial statements include the accounts of Security Devices International Inc. (the “Company” or “SDI”). The Company was incorporated under the laws of the state of Delaware on March 1, 2005.
	The accompanying unaudited interim financial statements have been prepared in accordance with the instructions to Form 10-Q and therefore do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with U.S. generally accepted accounting principles (GAAP); however, such information reflects all adjustments (consisting solely of normal recurring adjustments), which are, in the opinion of management, necessary for a fair statement of the results for the interim periods.
	The interim unaudited financial statements should be read in conjunction with the financial statements and Notes thereto together with management’s discussion and analysis of financial condition and results of operations contained in the Company’s annual report on Form 10-K for the year ended November 30, 2012. In the opinion of management, the accompanying unaudited financial statements reflect all adjustments of a normal recurring nature considered necessary to fairly state the financial position of the Company at August 31, 2013, the results of its operations for the nine -and three-month periods ended August 31, 2013 and August 31, 2012, and its cash flows for the nine -month periods ended August 31, 2013 and August 31, 2012. In addition, some of the Company’s statements in this quarterly report on Form 10-Q may be considered forward-looking and involve risks and uncertainties that could significantly impact expected results. The results of operations for the nine -month period ended August 31, 2013 are not necessarily indicative of results to be expected for the full year.
	The Company was incorporated under the laws of the state of Delaware on March 1, 2005.

XML

Property, Plant and Equipment, Schedule of Significant Acquisitions and Disposals (Details)	9 Months Ended
	Aug. 31, 2013 Y
Property And Equipment Property, Plant And Equipment, Schedule Of Significant Acquisitions And Disposals 1	30.00%
Property And Equipment Property, Plant And Equipment, Schedule Of Significant Acquisitions And Disposals 2	30.00%
Property And Equipment Property, Plant And Equipment, Schedule Of Significant Acquisitions And Disposals 3	20.00%
Property And Equipment Property, Plant And Equipment, Schedule Of Significant Acquisitions And Disposals 4	5

XML

SUBSEQUENT EVENTS

9 Months Ended

Aug. 31, 2013

SUBSEQUENT EVENTS [Text Block]

13.	SUBSEQUENT EVENTS
	a)	Subsequent to the quarter, the holder of a bridge loan exercised the holder’s right to convert the principal and interest (totaling CAD$382,014) into common shares at CAD$0.30 per share, resulting in the issuance of 1,273,378 common shares.
	b)	Subsequent to the quarter, the loan from related party for $94,970 (CAD$100,000) and loan from unrelated party for $189,940 (CAD $200,000) was repaid along with interest.

XML

COMMITMENTS

9 Months Ended

Aug. 31, 2013

COMMITMENTS [Text Block]

9.	COMMITMENTS
	a) Consulting agreements:
	The directors of the Company executed consulting agreements with the Company on the following terms:
	Effective January 1, 2013, SDI executed an agreement with a Company in which a director Allan Ezer has an interest in, for a period of two years to pay compensation of $8,500 per month with a 5% increase on the first anniversary date for services rendered. Either party may terminate the consulting agreement by giving 30 days written notice.
	Agreement with the Chief Executive Officer Greg Sullivan to pay compensation of $12,000 per month, with an annual 5% increase and a car allowance of $600 per month. The agreement expires December 31, 2016. The monthly remuneration will increase with accomplishment of milestones. The agreement may be terminated with mutual consent or by the Chief Executive Officer giving three weeks notice.
	Effective October 4, 2012, SDI executed an agreement with a Company in which the Chief Operating Officer Dean Thrasher has an interest in, for a period of two years which expires September 30, 2014 for services rendered. The total consulting fees are estimated at $480,000 for the two year period. The Company expensed $180,000 during the nine month period ended August 31, 2013. The Company may also accept common shares at $0.45 per common share in lieu of cash. As of August 31, 2013, the Company has not exercised its right to accept this compensation in shares.

SDI entered into an agreement (the “Teaming Agreement”) dated November 30, 2011 with Chemring Ordnance, Inc. (“Chemring”) pursuant to which both agreed to establish a co-operative and supportive team to develop the best marketing, management and technical approach for the worldwide manufacture and sale of 40mm less that blunt trauma ammunition. The Teaming Agreement provides for SDI and Chemring to create a team for the purpose of preparing competitive, cost effective proposals in response to requests for proposals and obtaining and performing any contracts that result therefrom.

Pursuant to the Teaming Agreement, if a contract is awarded, each of SDI and Chemring will perform the work to be done by it as specified in the Teaming Agreement and will share the revenue as set out in the Teaming Agreement. Either party who initiated the proposal that led to the contract will be the prime contact for that customer. Upon a contract being awarded to either SDI or Chemring, it will subcontract with the other for the other’s share of the work. In accordance with the Teaming Agreement, the BIP ammunition sold will have Chemring’s branding unless otherwise agreed by the parties.

The Teaming Agreement will terminate on December 20, 2016. The Teaming Agreement may also expire if a time period of two years from the effective date of the agreement passes without a bona fide arms length contract being executed and delivered with respect to BIP ammunition. It will also terminate if either party is in material breach of the Agreement or a subcontract that hasn’t been resolved, if any required governmental licenses or approvals or permits are revoked, in the event of a debarment or suspension of a party at the option of the other party, and by the mutual written agreement of the parties.

The Company entered into a Development, Supply and Manufacturing Agreement with the BIP Manufacturer on July 25, 2012. This Agreement provides the Company to order and purchase only from the BIP Manufacturer certain 40MM assemblies and components for use by the Company to produce less-lethal and training projectiles as described in the Agreement. The Agreement is for a term of five years with an automatic extension for an additional year if neither party has given written notice of termination prior to the end of the five year period.

Effective January 1, 2013, SDI executed an agreement with a non-related consultant to pay compensation of $7,000 per month. The consultant is to assist with sales initiatives, demos and participate in trade shows. The agreement is for a period of one year. Either party may terminate the consulting agreement by giving 30 days written notice.

Effective January 1, 2013, SDI executed an agreement with another non-related consultant to pay compensation of $7,000 per month. The consultant is to assist with sales initiatives, demos and participate in trade shows. The agreement is for a period of one year. Either party may terminate the consulting agreement by giving 30 days written notice.

b) The Company has commitments for leasing office premises in Oakville, Ontario, Canada to April 30, 2018 at a rent of Canadian $6,399 per month.

c) The Company has commitments for leasing office premises in Tampa, Florida, USA to June 30, 2014 at a rent of $1,418 per month.

XML

STOCK PURCHASE WARRANTS (Tables)

9 Months Ended

Aug. 31, 2013

Schedule of Stockholders' Equity Note, Warrants or Rights Issued on January 4, 2012 [Table Text Block]

Risk free rate		2.00%
Expected dividends		0%
Forfeiture rate		0%
Volatility		206.87%
Market price of Company’s common stock on date of grant of options	$	0.13
Compensation expense	$	100,148

Schedule of Stockholders' Equity Note, Warrants or Rights Issued on August 09, 2012 [Table Text Block]

Risk free rate		3.63%
Expected dividends		0%
Forfeiture rate		0%
Volatility		183.31%
Market price of Company’s common stock on date of grant of options	$	0.20
Compensation expense	$	75,013

Schedule of Stockholders' Equity Note, Warrants or Rights Issued on October 3, 2012 [Table Text Block]

Risk free rate		1.5%
Expected dividends		0%
Forfeiture rate		0%
Volatility		199.60%
Market price of Company’s common stock on date of grant of options	$	0.42
Compensation expense	$	28,911

Schedule of Stockholders' Equity Note, Warrants or Rights Issued on January 30, 2013 [Table Text Block]

Risk free rate		1.35%
Expected dividends		0%
Forfeiture rate		0%
Volatility		187.87%
Market price of Company’s common stock on date
of grant of options	$	0.47
Compensation expense	$	38,183

Schedule of Stockholders' Equity Note, Warrants or Rights Issued on March 14, 2013 [Table Text Block]

Risk free rate		1.35%
Expected dividends		0%
Forfeiture rate		0%
Volatility		182.13%
Market price of Company’s common stock on date of grant of options	$	0.40
Compensation expense	$	15,637

Schedule of Stockholders' Equity Note, Warrants or Rights Issued on April 12, 2013 [Table Text Block]

Risk free rate		1.35%
Expected dividends		0%
Forfeiture rate		0%
Volatility		168.05%
Market price of Company’s common stock on date of grant of options	$	0.35
Compensation expense	$	25,351

Schedule of Stockholders' Equity Note, Warrants or Rights Issued on May 14, 2013 [Table Text Block]

Risk free rate		1.35%
Expected dividends		0%
Forfeiture rate		0%
Volatility		181.17%
Market price of Company’s common stock on date of grant of options	$	0.35
Compensation expense	$	20,074

XML

PROPERTY AND EQUIPMENT (Tables)

9 Months Ended

Aug. 31, 2013

Property, Plant and Equipment, Schedule of Significant Acquisitions and Disposals [Table Text Block]

Computer equipment	30%	declining balance method
Furniture and Fixtures	30%	declining balance method
Leasehold Improvements		straight line over period of lease
Moulds	20%	Straight line over 5 years

Schedule of Property, Plant and Equipment [Table Text Block]

	August 31, 2013				November 30, 2012
			Accumulated				Accumulated
	Cost		Amortization		Cost		Amortization
	$		$		$		$
Computer equipment	37,573		30,592		37,573		28,565
Furniture and fixtures	18,027		13,575		18,027		12,282
Leasehold Improvements	23,721		9,283		8,252		8,252
Moulds	171,890		35,149		142,140		11,845
	251,211		88,599		205,992		60,944
Net carrying amount		$	162,612			$	145,048
Amortization expense		$	27,655			$	20,585
			(9months	)			(12months	)

XML

Document and Entity Information	9 Months Ended
	Aug. 31, 2013	Oct. 15, 2013
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Aug. 31, 2013
Trading Symbol	sdev
Entity Registrant Name	Security Devices International Inc.
Entity Central Index Key	0001354866
Current Fiscal Year End Date	--11-30
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		46,849,285
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well Known Seasoned Issuer	No
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3

XML

STOCK BASED COMPENSATION (Tables)

9 Months Ended

Aug. 31, 2013

Schedule of Share-based Compensation and Assumptions as of January 4, 2012 [Table Text Block]

Risk free rate		2.00%
Expected dividends		0%
Forfeiture rate		0%
Volatility		206.87%
Market price of Company’s common stock on date of grant of options	$	0.13
Stock-based compensation cost	$	113,292

Schedule of Share-based Compensation and Assumptions as of October 3, 2012 [Table Text Block]

Risk free rate		1.50%
Expected dividends		0%
Forfeiture rate		0%
Volatility		199.60%
Market price of Company’s common stock on date of grant of options	$	0.42
Stock-based compensation cost	$	77,096

Schedule of Share-based Compensation and Assumptions as of October 26, 2012 [Table Text Block]

Risk free rate		1.65%
Expected dividends		0%
Forfeiture rate		0%
Volatility		217.15%
Market price of Company’s common stock on date of grant of options	$	0.50
Stock-based compensation cost	$	534,905